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ABSTRACT
Glycemic Load and Risk of Alzheimer’s Disease:
The

Cache County Study on Memory,
Health, and Aging

by

Eun Young Choi, Master of Science
Utah State University, 2008
Major Professor: Dr. Ronald G. Munger
Department: Nutrition and Food Science

Carbohydrates are a major energy source for the human body and particularly
glucose is the only energy source for the brain. Thus glucose metabolism is important to
maintain normal brain function. Evidence showed insulin resistance and diabetes are
associated with cognitive decline and a large amount of highly processed carbohydrate
intake; in other words, a high glycemic load diet, which increases blood glucose faster
and insulin demand, is associated with increased risk of insulin resistance and diabetes.
Based on this premise, the hypothesis that a high glycemic load (GL) diet
increases the risk of incident Alzheimer’s disease (AD) was examined among Cache
County elderly people in Northern Utah. At the baseline survey, 3,831 participants 65
years of age or older completed a food frequency questionnaire (FFQ) and cognitive
screening. Observation time to collect the data for incident AD was approximately 10
years. Incident AD was determined by final consensus conference after multi-steps of
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screening. GL was calculated as the product of carbohydrate intake and glycemic index
(GI) and adjusted for energy intake. FFQs from diabetics were considered to be invalid
to assess dietary carbohydrates intake and excluded. The analysis was examined
separately by gender.
The Cox proportional hazard regression model in survival analysis was used to
relate GL to incident AD using a time variable with age of AD onset. There was no
association in men but a negative association in women in the unadjusted model.
Evidence of confounding by total kcal was apparent in women, particularly in the lowest
GL group, which had the highest total kcal mean intake. Finally no association between
GL and AD was found after adjustment for education, myocardial infarction (MI), stroke,
Body Mass Index (BMI), physical activity, smoking, alcohol use, APOE ε-4 alleles,
multi-vitamins use, total kcal, and controlling interaction between GL and total kcal.
The low GL group had unique characteristics in lifestyle factors, macro-nutrients
intake, and pattern of food use. The inverse relationship between GL and total kcal may
partly be explained by lifestyle factors, particularly alcohol intake. The characteristics of
low GL group, current smokers, alcohol users, and their relationship and interaction
between total kcal and risk of AD should be explored further.
(99 pages)
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INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that affects
millions in the aging population.

The prevalence of AD is estimated to increase three-

fold in the United States and four-fold worldwide from current affected number by 2050
(1, 2). AD is the fifth leading cause of death in Americans age sixty five and older in
2005 and has appeared as the third leading cost of care in medical condition in the United
States (1, 3). Sharply increasing number of AD patients indicates a growing socioeconomic burden due to increasing number of functional dependence of aging
populations, thus emphasis in strategies and efforts intended to maintain functional and
cognitive health may be particularly important to prevent occurrences of dementia and
AD.
The Cache County Study on Memory, Health, and Aging, established in 1994, is a
prospective cohort study of prevalence and incidence of dementia and AD among 5,092
Cache County elderly people in Utah (3). The study has contributed to deepening and
broadening the knowledge of AD in depth and breadth during four waves and three
follow-up assessments. Dietary factors such as anti-oxidant vitamins from supplements
and dietary intake and fruits and vegetables intake have been examined as modifiable risk
factors that may reduce risk of AD in the study.
Dietary carbohydrate intake affects the brain energy metabolism and may be an
important role in the pathology of AD. Substantial number of prospective cohort studies,
two cross sectional studies, and one meta-analysis of clinical trials found the association
between diabetes (4-8), insulin resistance (9-12), hyperinsulinemia (13-17), and increased
risk of cognitive decline and AD. Evidences provided from clinical trials, large
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prospective cohort studies, and population-based cross-sectional studies showed the
association between high dietary intake pattern of carbohydrates that are rapidly absorbed
from the gastrointestinal tract in term of glycemic index (GI) and glycemic load (GL) and
increased risk of insulin resistance and type II diabetes (18-28). Based on these premises,
the hypothesis that high glycemic load diet may increase the risk of AD is proposed.
However, there was little study on this hypothesis and no association between GL and the
risk of AD was found in a longitudinal cohort study (29).
Although supporting evidence from population studies are scant, the intent of this
study is to examine the association between higher glycemic load and the risk of AD
based on the following associations: association between glycemic index and glycemic
load and insulin resistance and type II diabetes, and association between insulin
resistance and type II diabetes and Alzheimer’s disease.
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REVIEW OF LITERATURE

Alzheimer’s disease
Alzheimer’s disease (AD) is not a normal part of aging but a progressive
neurodegenerative brain disease in the elderly population (30). It is characterized by
neuritic plaques from abnormally aggregated beta-amyloid peptide and intracellular
neurofibrillary tangles (NFTs) from paired helical filaments of hyperphosphorylated
microtubule-associated tau protein in the brain (30, 31). In 1907, Dr. Alois Alzheimer, a
German neuropathlogist and psychiatrist, was the first to report findings of senile plaques
and neurofibrillary tangles (31).
AD is the most common form of dementia accounting for 50 to 70 percent of the
total dementia cases, begining with early signs including memory loss and subtle
behavior changes (30). The symptoms of AD are not limited to memory loss and other
cognitive deficits but extend to a wide range of challenges, such as impaired activities of
daily life, depression, behavioral disturbances (30). Thus caring for AD patients becomes
a physical, psychological, emotional, and financial burden on the family and caregivers
along with the progression of the disease.
The mortality of AD had shown an increasing trend, particularly from 2000 to 2005,
deaths from Alzheimer’s disease increased by 44.7 percent, while the number one cause
of death, heart disease, decreased by 8.6 percent and percentages in other cause of death,
such as breast cancer, prostate cancer, and stroke tended to decrease (1). Approximately
5.2 million Americans were estimated to be affected by AD in 2008 (1). By 2050, the
number of people of age 65 and over with AD will increase by almost three-fold ranging
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from 11 million to 16 million if effective prevention or treatment are not available for the
disease (1). The growing prevalence of AD along with increased life expectancy has
appeared not only in the United States but also worldwide (1). Brookmeyer et al.
estimated that the worldwide prevalence of AD was 26.6 million in 2006 and this number
would increase fourfold, to 106.8 million in 2050 (about 1 in 85 persons) (32).
In the United States, direct and indirect costs of AD patients care, including
Medicare, Medicaid, and business of caregiving, are projected to be more than $148
billion annually (1). The worldwide cost for dementia care including AD is estimated to $
315 billion annually (33). This projected economic burden on medical cost along with
substantially increasing prevalence of AD, indicates its impact on public health and
imperative socioeconomic burden in near future. Therefore, it is crucial to study the
pathology of AD and to find potential modifiable risk factors to reduce incidence of AD
or to prevent cognitive impairment.
The risk of cognitive decline and AD, like other common chronic conditions, is
influenced by multiple clustering factors, such as age over 65 years, genetics (APOE ε-4
gene), chronic condition of insulin resistance, type II diabetes, inflammation, oxidative
stress, dietary factors, environmental factors (exposure to the exogenous substances, such
as metals and pesticides), lifestyles, education levels, gender, and head trauma (34).
Dietary factors are among modifiable risk factors and may play an important role in
prevention or precipitation of cognitive decline and AD. Dietary factors, such as calorie
restriction, homocysteine-related B-vitamins (vitamin B6, B12, folate), fatty acids
including cholesterol, polyunsaturated fatty acids (PUFA), omega-3 fatty acids,
docosahexaenoic acid (DHA) from fish linked to APOE ε-4 alleles, antioxidant nutrients
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related to oxidative stress, flavonoids, and alcohol have been studied to find a way to
reduce the risks of AD in prospective studies and clinical trials (34-38), but reports were
inconsistent (36, 37).
The application of nutrition to the epidemiologic study, especially related to
chronic diseases, is indeed complex because dietary components are highly interrelated to
each other and people eat a mixed diet, not isolated foods or individual nutrients (39, 40).
Thus, examining dietary patterns or food groups, which includes both macro- and micronutrients components, may capture the complexity of diet and be relevant in exploring the
association between dietary factors and chronic diseases. The data from the Cache
County on Memory, Health and Aging study by Wengreen et al. showed an example
focusing on the relation between food groups and cognitive decline and dementia in
which higher intakes of fruits and vegetables and consumption of fish at least once a
week were associated with reduced risk of cognitive decline or dementia, particularly
among ApoE4 non-carriers (41).
Mediterranean diet (MeDi) has received growing attention because of ecological
and observational evidence of reduced risk for cardiovascular disease (CVD), certain
forms of cancer, and overall mortality (25, 39). Recently the Washington Heights-Inwood
Columbia Aging Project (WHICAP) study among 2258 community-based non-demented
individuals, mean age of 77.2 years, by Scarmeas et al. showed that higher adherence to
the MeDi is associated with reduced risk for AD (39). The characteristics of the MeDi,
such as high intake of vegetables, legumes, fruits and cereals, olive oil, a moderate-high
intake of fish, a low to moderate intake of dairy foods, a low intake of meat and poultry,
and a regular but moderate amount of wine generally during the meals, seem to represent
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many potentially beneficial dietary components for AD (35, 39).
But there are not many studies regarding the effect of dietary patterns on the risk of
AD, thus with this perspective, diets low in GI and GL, which are characterized by more
whole-grain foods, fruits and vegetables with high in fiber, vitamins, and minerals, may
be good candidates dietary patterns to look into the reduced risk of AD.

Type II diabetes and Alzheimer’s disease
Type II diabetes is the product of progressive abnormalities: insulin resistance,
hyperinsulinemia, then pancreatic exhaustion as a result of the increased demand for
insulin in early stage and is characterized by hyperglycemia at an advanced stage (27, 4244). Type II diabetes mellitus is a pandemic public health problem; the global prevalence
of diabetes in 2000 was estimated at 171 million; by the year 2030, almost twofold of that,
about 366 million people, will be afflicted with diabetes (45, 46). The U.S. Centers of
Disease Control and Prevention estimated that total prevalence of diabetes in the United
States in 2005 was 20.8 million (7% of the population); 6.2 million people among
diabetes were undiagnosed and about 10 million, half of these persons, are aged 60 years
or older (47). It is indeed surprising that 6.2 million people, about one third of diabetes,
are undiagnosed. Diabetes is the sixth-leading cause of death and it is the most common
metabolic disorder that has been associated with various adverse health effects including
heart failure, stroke, kidney failure, and cognitive impairment and AD (48, 49).
Criteria for the diagnosis of diabetes in non-pregnant adults are shown in Table 1
from the American Diabetes Association (ADA) (50). There are three ways to diagnose
diabetes, and each must be confirmed on a subsequent day unless clear symptoms of
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hyperglycemia are present (50). Although the 75g oral glucose tolerance test (OGTT) is
more sensitive than fasting plasma glucose (FPG) to diagnose diabetes, the FPG test is
preferred in practice because it is easy to use, costs less, and is more acceptable to
patients than the OGTT test (50).
By ADA definition, impaired fasting glucose ( IFG=fast plasma glucose 100 mg/dl
(5.6 mmol/l) to 125 mg/dl (6.9 mmol/l)) and impaired glucose tolerance ( IGT= 2-h
plasma glucose 140 mg/dl (7.8 mmol/l) to 199 mg/dl (11.0 mmol/l))have been officially
termed “pre-diabetes” and both categories, IFG and IGT, are risk factors for future
diabetes and cardiovascular disease (50).
Type II diabetes has been associated with cognitive decline and AD in their
pathogenesis and disease progress linked to underlying mechanism of insulin resistance
(43, 49). First of all, Stewart et al. showed that type II diabetes elevated the risk of both
vascular dementia and AD (51).

Table 1. Criteria for the diagnosis of diabetes (cited from ADA)
* Symptoms of diabetes and a casual plasma glucose

≥

200 mg/dl (11.1 mmol/l)

Casual is defined as any time of day without regard to time since last meal.
The classic symptoms of diabetes include polyuria, polydipsia,
and unexplained weight loss.
* FPG

≥126

mg/dl (7.0 mmol/L)

Fasting is defined as no caloric intake for at least 8 hours
* 2-hour plasma glucose

≥

200 mg/dl (11.1 mmol/L) during an OGTT

OGTT test: glucose load containing 75 g anhydrous glucose dissolved in
water
FPG, fasting plasma glucose; OGTT, oral glucose tolerance test
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In the early population-based prospective cohort study (the Rotterdam study) and
later study in which 6,370 elderly people participated for 2.1 years, Ott et al. found that
people with diabetes had almost a doubled risk of dementia and AD (relative risks with
proportional hazard regression; both RR = 1.9) and more importantly patients receiving
insulin treatment were at highest risk of dementia (RR = 4.3) (6, 52).
The Honolulu-Asia Aging Study conducted by Peila et al. with a population-based
cohort of 2,574 Japanese-American men, found that diabetes was associated with total
dementia, AD, and vascular dementia and the association between diabetes and AD was
particularly strong among APOEe4 carriers (7). Another cohort study, in which 1,789
Latinos aged 60 and older participated during 1998-1999, showed that risk of dementia
was nearly eight times higher in people with type II diabetes and stroke (53). The largest
cohort, Nurses’ Health Study, in which 18,999 women aged 70-81 years participated for
2 years, reported women with type II diabetes had increased odds of poor cognitive
function and substantial cognitive decline (54). Arvanitakis et al. also found evidence
among 824 older Catholic nuns, priests, and brothers (55).
However, the Canadian Study of Health and Aging by Mcknight et al. found
contradicting result that no significant association existed between diabetes and AD, but
significant with vascular impairment (56). Yamada et al. also had no significant finding in
the Hiroshima Adult Health Study (57). In a historical prospective cohort study of
Japanese-American men (n =3774) who were examined at ages 45 to 68 (1965 through
1968) and again at ages 71 to 93, (1991 through 1993) there has no relation of a 15-year
or 25-year history of diabetes to AD (58), but a later study with the same sample
mentioned above (the Honolulu-Asia Aging Study) showed patients with type II diabetes
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had a significant association with AD (7).
Similarly, the early population-based study by Hassing et al. (59) found no
association in AD with diabetes, but later longitudinal population-based study found that
type II diabetes was associated with accelerated cognitive decline (60). Luchsinger et al.
also produced conflicting results that had no significant diabetes-AD association among
Blacks and Hispanics in their earlier study (5), but later studies showed that diabetes and
current smoking were the strongest risk factors (4). The strong association between
hyperinsulinemia and risk of AD among multiethnic elderly in Northern Manhattan was
also found (13). Recently, Luchsinger et al. reported evidence of association between
diabetes and higher risk of mild cognitive impairment (MCI) among same group,
Northern Manhattan 1772 elderly people (61). Finally, in the Cache County Study on
Memory, Health, and Aging, Charoonruk et al. found association of AD and type II
diabetes in men (62).
To conclude, most longitudinal and population based cohort studies or crosssectional studies have shown an increased risk of AD associated with diabetes and insulin
resistance (hyperinsulinemia) even though some studies showed conflicting results.
Furthermore, in several study groups, earlier findings weren’t significant, but later
follow-ups showed significant results. Therefore, a strong body of studies supports a
notion that type II diabetes may increase risk of AD. However, special attention may be
needed in large population studies because considerable large proportion of type II
diabetes were undiagnosed due to dependence on self-report or medical record for the
diagnosis of diabetes (63). Also, increasing interest on pre-diabetes stage, which is
characterized by insulin resistance and hyperinsulinemia, has produced some evidence of
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possibility that insulin resistance may independently associated with AD risk (63).

Insulin resistance and Alzheimer’s disease
Insulin is a polypeptide consisting of alpha(α) and beta (ß) chain of 21 and 30
amino acids and is linked through a pair of disulfide bonds (64). It is synthesized from
the ß cells in the pancreas by cleavage of a C-terminal 23-amino-acid sequence of porcine
proinsulin, thus it is produced with C peptide which is its by-product and often used as a
measure of insulin production (64). The half-life of insulin is about 5 minutes and it is
normally degraded in the liver, kidney and muscles by insulin degrading enzyme (IDE), a
thiol methalloprotease (42, 64).
Insulin is the only hormone that directly lowers blood glucose levels and plays the
dominant role in the control of carbohydrate metabolism and also regulates fat and
protein metabolism in many peripheral target tissues, such as hepatic cells, muscle cells,
and adipose cells (64). For example, as the most important actions of insulin, insulin not
only enhances the uptake of glucose in cells, where it is metabolized and stored as
glycogen in the liver, but also stimulates protein synthesis in muscles as well as lipid
synthesis in adiposities (64). Thus lack of insulin results in reversing action including
lipolysis, ketogenesis, proteolysis due to unavailability of glucose and, ultimately, death
(64).

If excess insulin is prolonged, it may result in hypoglycemia with consequent

brain failure and again, finally, death (64).
Other important actions of insulin are the effect on normal growth process and
promotion of the full anabolic effect of growth hormone (64). Insulin is required for the
action of growth hormone (GH) through its action on glucose uptake by muscle, and
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provides the energy substrates necessary for protein synthesis and also its direct action on
amino acid transport into the cells as well as RNA synthesis (64). For this reason,
children with diabetes may experience dwarfism because insulin has an important role for
the full anabolic effect of GH mainly in protein synthesis, and possibly due to the
structural similarity of insulin, insulin-like-growth hormone-I (IGF-I), and their receptors
(64).
Another important action of insulin is to maintain potassium (K+) homeostasis by
stimulating K+ uptake by cells, thus hyperinsulinemia may cause hypokalemia (potassium
level less than 3.5 mEq/L) (64). The effect on insulin in the brain is less well defined
compared with the effects on peripheral tissues. Historically, the brain has been described
as an insulin-insensitive tissue; however, recent views on insulin in the brain suggested
that insulin has important roles in the central nervous system (CNS). Craft et al. and
Gerozissis described that peripheral insulin from the pancreatic beta cells can be
transported into (CNS) both via across blood-brain barrier (BBB) by saturable, insulin
receptor-mediated transport process and the cerebrospinal fluid (CSF) reached through
circumventricular regions which is deficient in BBB (63, 65, 66). Saturability of glucose
transport through the BBB was discovered by Banks et al. who explained the nonlinear
relationship between the concentrations of human insulin in brain and blood, so insulin
enters the brain by a saturable transport system (67). There is a hypothesis of biosynthesis
of insulin in the brain from some studies (66, 68), but it is still inconclusive (63).
Raising of the peripheral insulin concentration increases insulin concentration in brain
and CSF, while chronic periphery hyperinsulinaemia down-regulates BBB insulin
receptors thereby reducing insulin transport into the brain resulting in brain-insulin
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deficiency (12, 63, 69)
Insulin receptors (IR) are highly concentrated in several specific brain regions
including the choroid plexus, olfactory bulb, piryform cortex, amygdaloid nucleus,
hippocampus, hypothalamic nucleus, and cerebellar cortex that control fundamental
behaviors such as food intake, reproduction, and cognition (42, 63, 66, 70).
Glucose transport (GLUT) is mediated by 13 members of GLUTs family and
expressed in specific cells and tissues; GLUT 1, 2, and 3 have been known to be not
regulated by insulin, but GLUT 4 and 8 are insulin-sensitive transporters which increase
glucose uptake 10- to 40-fold within minutes by translocation into membrane through
insulin signaling cascade (42). GLUTs in CNS are mediated by mainly GLUT 1, 3, 4 and
8; GLUT 1 and 3 are widespread in the brain; but insulin-sensitive GLUT 4 and 8 are
selectively distributed in the brain, such as in the hippocampus and hypothalamus,
indicating the effect of insulin in selective brain regions supporting memory (42, 71, 72).
Craft has studied brain aging and described the role of insulin in the brain in her
review paper which reported that insulin enhances memory with optimal plasma insulin
levels of 10-20 µU/ml and sufficient glucose (69). This notion is supported by both
animal (intracerebroventricular administration of insulin in rodents) and human
(intravenous and intranasal insulin administration) studies which memory is facilitated by
administration of insulin (11, 73). Insulin-modulated glucose utilization affects levels of
neurotransmitters, such as acetylcholine and noreepiniphrine, that play important roles in
cognition and long-term potentiation (LTP) of memory (12, 66, 69). Insulin also promotes
rapid delivery of N-methyl-D-aspartate receptors to the cell membrane by exocytosis to
modulate membrane potentials and neuronal firing/LTP in hippocampus (74, 75).
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Gerozissis described insulin as a neuromodulator involved in neurotransmitter
release and also as a regulator for food intake behavior and energy homeostasis related to
body weight in hypothalamus (66, 76). Zhao examined the role of insulin and insulin
receptor in learning and memory through molecular mechanism associated with cognitive
function and aging (68). Insulin and insulin receptor modify neurotransmitter release
processes at various types of presynaptic terminals and modulate the activities of both
excitatory and inhibitory postsynaptic receptors (68). They also explained molecular
mechanism of insulin and insulin receptor activities in the brain that insulin and insulin
receptors participate in regulation of learning and memory through activation of specific
pathways such as shc, Grb-r/SOS, Ras/Raf, MEK/MAP kinases, IRS1, PI3 kinase, and
protein kinase C in the formation of long-term memory formation (68).
Another role of insulin and IGF-1, which has similar molecular structures, in Aß
clearance is that insulin increases Aß secretion by trafficking intracellular Aß from the
Golgi to the plasma membrane and then IGF-1 enhances the transport of Aß carrier
proteins (albumin and transthyretin) into the brain (77, 78).
Therefore, peripheral insulin hormone has an important role in blood glucose
homeostasis, the regulation of macronutrient metabolism, normal growth and
development, and potassium (K+) homeostasis. In the brain, insulin is involved in
memory, cognitive process with selective distribution of insulin, its receptors, and
transporters, energy balance, and food intake behavior (12, 71, 75). Furthermore, insulin
has an important role in Aß metabolism that increases Aß secretion and decreases the
intracellular levels of Aß via intracellular trafficking mechanism (78).
Insulin resistance is a diminished ability of cells to respond to the action of insulin

14
in transporting glucose from the bloodstream into muscle and other tissues and is a prediabetes condition that appeared in 41 million people ages 40 – 74 (about 40% of US
adult) in 2000 data from the U.S. Department of Health and Human Services (79).
Reaven described “the insulin resistance syndrome” with a broad range of physiological
abnormality rooted to insulin resistance as listed in Table 2 (80).
From a molecular perspective, mechanism of insulin resistance can be divided into
three categories; receptor, pre-receptor, and post-receptor insulin resistance (64). The
majority of insulin resistance can be explained by the mechanism of the post-receptor
insulin resistance due to the failure of signaling of insulin’s action by some intracellular
effectors (64). Petersen et al. proposed a plausible mechanism of this post-receptor
insulin resistance via the defects in insulin-stimulated muscle glycogen synthesis and
increased intracellular lipid accumulation in muscle and liver tissue (48).
Their mechanism is that increasing plasma fatty acid levels raises intracellular lipid
metabolites, such as fatty acyl CoAs and diacylglycerol, which in turn activate protein
kinase C (PKC), thus leading to defects in insulin signaling through phosphorylation of
insulin receptor substrate (IRS)-1 (48).
Blunted insulin-stimulated IRS-1 tyrosine phosphorylation by increasing PKC
activity reduces phosphatidylinositol (PI) 3-kinase activity, which plays an essential role
in insulin-stimulated glucose transport activity (GLUT 4), thereby resulting in reduced
insulin-stimulated muscle-glycogen synthesis and increased plasma blood glucose levels
(48). Thus increased intracellular lipid metabolites trigger the insulin resistance through
the mechanism described above and this intracellular fat-induced insulin resistance
mechanism is especially important.
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Table 2. Abnormalities related to insulin resistance
and hyperinsulinemia (cited from Reaven (80))
* Some degree of glucose intolerance
Impaired fasting glucose
Impaired glucose tolerance
* Dyslipidemia
↑ Triglycerides
↓ HDL-C
↓ LDL-particle diameter (small, dense LDL particles)
↑ Postprandial accumulation of triglyceride-rich lipoproteins
* Endothelial dysfunction
↑ Mononuclear cell adhesion
↑ Plasma concentration of cellular adhesion molecules
↑ Plasma concentration of asymmetric dimethylarginine
↓ Endothelial-dependent vasodilatation
* Procoagulant factors
↑ Plasminogen activator inhibitor-1
↑ Fibrinogen
* Hemodynamic changes
↑ Sympathetic nervous system activity
↑ Renal sodium retention
* Markers of inflammation
↑ C-reactive protein, white blood cell count, etc.
* Abnormal uric acid metabolism
↑ Plasma uric acid concentration
↓ Renal uric acid clearance
* Increased testosterone secretion (ovary)
* Sleep-disordered breathing
HDL-C, high-density lipoprotein cholesterol; LDL, low-density lipoprotein.
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Morino and Petersen et al. linked this intracellular fat-induced insulin resistance
mechanism to mitochondrial dysfunction through magnetic resonance spectroscopy
studies in healthy lean elderly subjects and healthy lean insulin-resistant offspring of
parents with type II diabetes (45). They hypothesized that reduced mitochondrial function
may predispose these individuals to intramyocellular lipid accumulation and insulin
resistance (45). They assessed mitochondrial oxidative phosphorylation activity in the
healthy lean elderly people and observed about 40% reduction in rates of this activity
which is associated with increased intramyocellular and intrahepatic lipid content (45).
For the Insulin-resistance offspring of patients with type II diabetes, their inherited
condition causes a reduction in mitochondrial content in skeletal muscle by 38%, which
in turn reduced rates of mitochondrial oxidative phosphorylation predisposing them to
intramyocellular lipid accumulation by about 80% increase in its lipid content (45).
In conclusion, molecular mechanisms in peripheral insulin resistance underscore
the role of intracellular content of lipid in liver and skeletal muscle rather than absolute
quantity of body fat. Obviously, insulin resistance occurs often in obese people because
excess of caloric intake leads to fat accumulation not only in adipocytes, but also in
muscle and liver cells. It also may occur in healthy and lean elderly people who acquired
age-associated decline in mitochondrial function or inherited insulin-resistant offspring of
parents with type II diabetes who have inherited reduction in mitochondrial density via
mitochondrial dysfunction mechanism (45, 48).
Petersen et al. provided evidence supporting the hypothesis described above as
skeletal muscle insulin resistance mechanism from their recent human study (81). They
reported the pattern of energy distribution derived from two high-carbohydrate meals in
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young, lean, insulin-resistant individuals compared with young, lean, insulin-sensitive
individuals (81). Their finding was that net muscle glycogen synthesis was reduced by
about 60% in young, lean, insulin-resistant subjects compared to controls; on the contrary,
hepatic de novo lipogenesis and hepatic triglyceride synthesis were both increased by
greater than two fold in the insulin-resistant subjects, consequently resulting in increased
plasma triglyceride concentration by 60% and decreased plasma high-density lipoprotein
(HDL) concentration by 20% (81). The result indicates that insulin resistance in skeletal
muscle can promote atherogenic dyslipidimia by changing the pattern of ingested
carbohydrate away from skeletal muscle glycogen synthesis into hepatic de novo
lipogenesis (81).
Insulin resistance has a well known role in the metabolic syndrome, also known as
the insulin resistance syndrome or syndrome X, which is a cluster of symptoms that
include central obesity (men: waist circumference > 40 inches, women: waist
circumference> 35nches), hyperglycemia (fasting glucose ≥ 110, < 126 mg/dl) ,
hypertension (blood pressure ≥ 130/80 mm Hg), dyslipidaemia (triglycerides ≥ 150
mg/dl) , and low-HDL level (men < 40 mg/dl, women < 50 mg/dl) (80). The metabolic
syndrome is estimated to affect more than 50 million Americans and approximately half
of all Americans are predisposed to it (81). This cluster of metabolic anormalities have
been linked to an increase in the risk of chronic diseases including CVD, CHD, type II
diabetes, and AD.
Watson and Craft et al. have intensively studied the role of insulin resistance
particularly in the pathogenesis of AD. They explained that in the periphery, the most
direct effects of insulin resistance are compensatory hyperinsulinemia and hyperglycemia
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whereas in the CNS, insulin resistance may alter glucose metabolism in selective brain
regions, as there is a unique distribution of insulin receptors and insulin-sensitive GLUTs
in the hippocampus and adjoining medial temporal cortex (12, 42, 71, 72). Craft
emphasized an important consequence of insulin resistance syndrome and reduced insulin
transport into the brain, which causes brain insulin deficiency (12). Finally this
insufficient insulin concentration in the brain compromises beneficial roles of insulin in
CNS, thereby increases the risk of age-related memory impairment and AD (12). Other
studies from Craft et al. have provided evidence for the association between insulin
resistance and risk of cognitive impairment and AD. At first, in their 18 months
longitudinal controlled clinical trial, they examined the effect of hyperglycemia on
hormone levels, metabolite levels, and memory performance in 22 subjects with very
mild and mild probable dementia of the Alzheimer type (DAT) and in 12 normal elderly
adults (82). Subjects were tested in 3 plasma glucose conditions (fasting baseline, 175
mg/dl, and 225 mg/dl) at initial and 18-month follow-up sessions. For the initial session,
adults with very mild DAT showed memory facilitation and elevations in plasma insulin
in the 225-mg/dl glucose condition relative to baseline, and then at follow-up, very mild
DAT patients whose dementia had progressed showed significant decreases in insulin and
hyperglycemic memory facilitation (82). This finding suggested that glucoregulatory
abnormalities may contribute to the pathophysiology of DAT (82).
The following study explored whether memory improvement is due to a secondary
elevation in plasma insulin levels, independent of hyperglycemia (83). They found that
raising plasma insulin through intravenous infusion while keeping plasma glucose at a
fasting baseline level produced striking memory enhancement for patients with DAT (83).
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This finding proposed that neuroendocrine factors (insulin, insulin receptors, and insulinmediate glucose utilization) play an important role in the pathophysiology of DAT (83).
Their continued clinical trial examined the effects of hyperinsulinemia acutely in
older adults and in patients with AD using a hyperisulinemic-euglycemic clam. They
found that normal older adults had a memory facilitation in plasma insulin levels of 10-20
µU/ml (optimal levels in normal physiological condition) with low-doses of insulin
administration, while AD patients with insulin resistance needed higher insulin doses
achieving levels of 60-85 µU/ml to facilitate memory (84). They also found interesting
results in the subgroup of AD patients with insulin resistance came from mainly nonAPOE ε-4 carriers indicating that insulin resistance may play an important role in
pathogenesis of AD and may independently associated with increased risk of AD (84).
Another clinical trial by Craft et al. with insulin treatment in 16 healthy older
adults (mean age 68.7 years) examined insulin effects on CSF Aß42 levels (85). The
result was that insulin infusion facilitated memory, however it increased CSF Aß42 levels
particularly in older subjects and such memory facilitation was attenuated in the subjects
with the greatest increase in CSF Aß42 levels (85). This study is consistent with role of
insulin on Aß metabolism which increases CSF Aß levels by facilitating intracellular Aß
trafficking to the membrane suggested by Gasparini et al. and implicating abnormal
insulin metabolism in the pathophysiology of AD.
Fishel and the Craft laboratory studied the effects of peripheral hyperinsulinemia
on inflammation in the CNS through a similar experimental design with previous Aß and
hyperinsulinemia study (86). Sixteen healthy older adults (mean age 68.2 years) received
insulin infusion achieving plasma typical insulin resistance levels (>20 uU/mL) for 105
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minutes and measured both plasma and CSF levels of inflammatory markers, cytokines
(IL-1ß, IL-6, TNF-α, and F2-isoprostane (CSF only)) and Aß42. The result was that
insulin increased CSF levels of F2-isoprostane and cytokines (both P<.01), as well as
plasma and CSF levels of Abeta42 (both P<.05). These synchronous hyperinsulinemiainduced increases in Aß42 and inflammation markers in the CNS may increase the risk of
AD (86).
Craft et al. proposed a model that their main hypothesis, in which insulin resistance
and hyperinsulinemia contribute to the pathogenesis of AD, was linked to obesity through
free fatty acids (FFAs) (87). Their mechanism is that peripheral insulin resistance and
hyperinsulinemia increase peripheral FFA levels, which in turn elevate inflammatory
agents in both periphery and CNS, reduce activity of insulin degrading enzyme,
consequently inhibit peripheral Aß uptake and clearance, thereby increasing plasma Aß
levels and elevate Aß transport into the brain (12, 87). This chain of effects is exacerbated
by age and obesity (12, 87). Their cumulated experimental studies, based on the
association between insulin resistance and AD, seemed to be integrated into this model.
Craft pointed out the possibility that insulin resistance independent of diabetes or
APOE ε-4 gene may increase the risk of AD (63) and population-based cross-sectional
studies have provided evidence for this association.
Kalmijn et al. from the Netherlands studied the cross-sectional association of
cognitive function with hyperinsulinemia, impaired glucose tolerance (IGT), and diabetes
in 462 men aged 69 to 89 years (88). They found that diabetes as well as non-diabetic
subjects with IGT and hyperinsulinemia had impaired cognitive function as measured by
the Mini-Mental State Examination (MMSE) (88). Another cross-sectional study of 980
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people aged 69 to 78 (349 men, 631 women) from eastern Finland by Kuusisto et al.
measured the insulin resistance syndrome and diagnosis of AD and found that in 532 nondiabetic subjects without the APOE ε-4 allele, hyperinsulinemia was associated with an
increased risk for Alzheimer's disease (prevalence of disease 7.5% v 1.4% in
normoinsulinemic subjects, P = 0.0004) whereas in the 228 with the APOEe4,
hyperinsulinemia had no effect on the risk of disease (7.0% v 7.1%, respectively) (17).
This study suggested that insulin resistance syndrome is associated with Alzheimer's
disease independently of APOEε-4 phenotype (17). Furthermore, a recent populationbased cohort study conducted by Luchsinger et al explored the association between
hyperinsulinemia and risk of AD (13). 683 elderly people without dementia from
northern Manhattan were followed-up for 3.7 years and the result was that the risk of AD
doubled in the 39% of the sample with hyperinsulinemia (hazard ratio (HR) = 2.1; 95%
CI: 1.5, 2.9) and was highest in people without diabetes indicating that higher insulin
levels were related to the risk of dementia and particularly the cases with diabetes with
highest HR was noticeable finding which adds a strong evidence of independent
association between insulin resistance and AD (13, 63).
In addition, the population-based cohort study (1990-1991) of 959 elderly subjects
from eastern Finland on the association of metabolic syndrome with AD by Vanhanen et
al. provides more evidence for the independent association (89). They found that
metabolic syndrome was significantly associated with AD in multivariate logistic
regression analysis (OR = 2.46; 95% CI 1.27 to 4.78) and also this significant association
appeared in people without diabetes (OR = 3.26; 95% CI 1.45 to 7.27) (89).
In summary, insulin resistance may increase the risk of age-related memory
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impairment and AD through possible mechanisms mentioned above and many evidences
from population-based studies give the possibility of its independent association to AD
among non-diabetes.

The role of glycemic index/ glycemic load
in insulin resistance and type II diabetes
Carbohydrates have been traditionally classified as ‘simple carbohydrates’ or
‘complex carbohydrates’ based on their chemical structure (the length of sugar compound
chain) (90). Simple carbohydrates that have one or two sugar molecule (mono or
disaccharides) such as fruit sugar (fructose), corn sugar (glucose), and table sugar
(sucrose), which are considered as ‘bad carbohydrates’ whereas complex carbohydrates
that are considered ‘good carbohydrates’ include any sugar molecules that have more
than three linked sugar compounds (polysaccharides) (90).
However, most digestible carbohydrates can be converted into glucose to be used
as an energy source for the body. Therefore, the judgment of carbohydrate as ‘good’ or
‘bad’ by old assumption is ambiguous because it does not explain how different types of
carbohydrates physiologically affect plasma glucose and insulin responses, thereby,
implicating health effects. For this reason, GI was proposed in 1981 by Jenkins et al to
classify carbohydrate-containing foods according to their postprandial glycemic effect
which has a basic idea that food sources of carbohydrate vary greatly in their rate of
absorption and physiological effects on blood glucose and insulin concentrations (27, 91).
GI is defined as an index of the postprandial glucose response of a food, compared
with a reference, usually glucose or white bread (92). It represents the incremental area
under the curve of blood glucose produced by a standard amount of carbohydrate in a
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food (test food), usually 50g, relative to the incremental area produced by the same
amount of carbohydrate from standard source (reference food), usually white bread or
glucose as shown in Figure 1 and the formula for GI calculation is as follows: (27, 92)
GI = (Blood glucose area under the curve (AUC) of test food/ blood glucose AUC of
referenced food) x 100 (92).
It is determined by feeding 10 or more healthy people a portion of the food
containing 50 grams of digestible carbohydrate after an overnight fast and then fingerprick blood samples are taken at 15-30 minute intervals to measure the effect on their
blood glucose levels over the next two hours so that for each person, the area under their
two-hour blood glucose response (glucose AUC) for the test food is measured (93).

Figure 1. Measurement of Glycemic Index (cited from www.glycemicindex.com)
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On the other hand, the same 10 people consume an equal-carbohydrate portion of
glucose sugar (the reference food) and their two-hour blood glucose response is also
measured and then a GI value (% ranking) for the test food is then calculated for each
person by dividing their glucose AUC for the test food by their glucose AUC for the
reference food and then multiplying by 100. The final GI value for the test food is the
average GI value for the 10 people (93).
GI is a ranking of carbohydrates on a scale from 0 to 100 according to the extent to
which they raise blood glucose levels after intake of carbohydrate-containing foods.
Foods with a high GI (greater than 70) indicate that they are rapidly digested and
absorbed and result in a marked increase in blood glucose levels. On the contrary, low-GI
foods (less than 55) are slowly digested and produce gradual rises in blood glucose and
insulin levels.
Augustin et al. described the factors that may affect GI values, as follows: ratio of
amylase to amylopectin present in the raw food (more amylopectin, higher GI), the type
of monosaccharide components (glucose ↑ or fructose ↓), the amount and type of dietary
fiber (increasing soluble fiber, decreasing GI), cooking and food processing, particle size
(more processing, increasing GI), ripeness, α-Amylase inhibitors such as phytic acid,
lectins, and tannins (↓ GI), and the presence of large amounts of fat or protein (↓ GI) (94).
Assessment of carbohydrate quality using glucose as the reference was made with
international Table that contained more than 500 foods was produced by Foster-Powell
and Brand-Miller et al. at the University of Sydney in 1995 and then it was revised and
compiled to “ International Tables of Glycemic Index and Glycemic Load Values: 2002”
which was containing nearly 1300 data entries representing more than 750 different types
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of foods (91).
2002 version of GI table contained mainly carbohydrate foods that were classified
into twenty two food groups (91). There were no GI values in the table for foods
containing little or no carbohydrate such as meat, fish, eggs, avocados, cheese, and salad
vegetables because clinical determination of GI is required a person to consume a serving
of food containing at least twenty five to fifty gram of carbohydrate (95).
Glycemic load (GL) was first introduced in 1997 by Willett et al. at Harvard
School of Public Health and is defined as a measure that incorporates both the quantity
and quality of dietary carbohydrate (27, 92). GL is calculated by multiplying the amount
of carbohydrate by its glycemic index and the formula is as follows (27, 92):
GL = (GI of individual food x g carbohydrate per serving of food)/ 100 (92).
Each unit of dietary GL represents the equivalent of one gram of carbohydrate from
white bread or glucose (96). Physiological implication of GL is that the GI is more
important when carbohydrate intake is high (27). Dietary glycemic load can be estimated
as the sum of the glycemic loads of all carbohydrate foods consumed during a day (27,
97). Brand-Miller et al. validated the concept of GL with the clinical trial in lean young
adults (97) and Galgani et al. showed GL was useful in predicting the acute impact on
blood glucose and insulin response within mixed meals (98).
There have been existing continuous criticisms on the glycemic index concept such
as GI values in the mixed meals (difference in GI value will be lost in mixed meal due to
the effects of protein and fat contents). It is less practical application to people due to its
difficult concept and potential dietary restriction, and issue on beneficial foods with high
GI (99).
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Kendall et al. and Willett et al. addressed these issues. For the first issue on GI
values in the mixed meals, the study results from Wolever et al. and Bornet et al. have
shown that fat and protein did not affect the relative differences between carbohydratecontaining foods (27, 99-101). Willett et al. explained the way of calculation in the total
GI from mixed foods as a weighted average of the GI values of the individual foods, with
the weights corresponding to each food’s carbohydrate content (27).
In the recent study, Wolever et al. ascertained their finding with the use of
crossover design in both Sydney and Toronto and concluded that GI was a significant
determinant of the glycemic effect of mixed meals in normal subjects and GI explained
approximately 90% of the variation in the mean glycemic response, with protein and fat
having negligible effects (28).
For the second issue, Kendall et al. answered that GI might simply be used as a tool
for selecting better quality starchy foods (99). For the last issue, some foods, such carrots
have been condemned because they have a high GI, but maybe, this issue can be
explained with GL concept from Willett et al.
The glucose and insulin responses depend on both the quantity and quality of the
carbohydrate and GL represents both of these components of carbohydrates, thus even
though carrots have high glycemic index, GL of carrots is very low because they have
small amount of carbohydrate implicating little impact on blood glucose (27, 99). In
general, low calorie foods such as fruits and vegetables that have high GI tend to have no
significant effect on blood glucose levels and they also have high levels of beneficial
factors such as fiber, vitamins, and minerals (99). Therefore, GI may be a useful tool for
selecting better quality starchy foods and GL may be more relevant to apply the concept
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of GI to whole mixed meals and overall diet.
GI and GL have been related to chronic diseases such as insulin resistance, type II
diabetes, coronary heart disease (CHD), obesity, colon cancer, and breast cancer (94).
Because GI was driven by the effects of carbohydrate-containing foods on blood glucose
and insulin concentration, GI and GL have been associated with insulin resistance but not
all, type II diabetes, and metabolic syndrome in clinical trials, large prospective cohort
studies, and population-based cross-sectional studies.
Epidemiological evidences from Nurses’ Health Study and Health Professional
study by the same group, Salmeron et al. showed a significant association between GI
expressed as GL and risk of diabetes that diets with a high glycemic load and a low cereal
fiber content increased risk of diabetes in both men and women (18, 19).
In the other cohort study, Meyer et al. followed 35,988 women who completed the
same dietary questionnaire used in the Nurses’ Health Study for 6 years and found that
total carbohydrates intake, GI, GL, fruits & vegetables were not associated with risk of
diabetes whereas whole-grain intake and cereal fiber were inversely associated with
diabetes (102). In response to this finding, Willett pointed out the lack of association with
GI or GL in Meyer’s study may have been related in part to use of a single measure of
dietary intake and self-reported diabetes without confirmatory information (27).
The relation between whole-grain consumption and the risk of type II diabetes
among women in the Nurses’ Health Study was examined by Liu et al. who has
collaborated with the Harvard study group and the results were that women in the top
quintile of whole-grain intake (median: 2.7servings/d) had a 27% lower risk of diabetes
than did those in the lowest quintile (median: 0.13 serving/d) and the ratio of refined to
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whole grains was significantly associated with risk of diabetes (103). Follow-up study of
42,898 men from the Health Professionals reported the same confirmative results with
Lie by Fung et al who again involved in the same study group (21).
The Nurses’ Health Study II by Schulze et al. examined the association between GI,
GL, and dietary fiber and the risk of type II diabetes in a large cohort of young women
and they found that GI was significantly associated with an increased risk of diabetes and
cereal fiber intake was associated with a decreased risk of diabetes but GL was no
significant association (26).
In the other cohort study, McKeown et al. examined the cross-sectional association
between whole- or refined-grain foods and several metabolic markers of disease risk in
their early Framingham Offspring Study and found that increased intakes of whole grains
was inversely associated with reduced metabolic risk factors (104) and then their followup study explored the associations between carbohydrate-related dietary factors including
total dietary carbohydrate, fiber, whole- and refined-grain foods, GI, and GL, insulin
resistance, and the prevalence of the metabolic syndrome in 2,834 subjects at the fifth
examination (1991-1995) (23). Their results were continuum of similar results that
whole-grain intake, largely attributed to the cereal fiber, was inversely associated with
Homeostasis model assessment of insulin resistance (HOMA-IR) and a lower prevalence
of the metabolic syndrome but GI was appeared as an opposite result (23). Sahyoun et al.
from the same cohort study examined the same cross-sectional association in older adults
aged 60-98 years and the results showed a significant inverse association between wholegrain intake and metabolic syndrome and mortality from CVD (24).
An interesting cross-sectional study from Japan examined the cross-sectional
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association between GI and GL and several metabolic risk factors including BMI, fasting
triacylglycerol, fasting blood glucose, and glycated hemoglobin in healthy Japanese
women with traditional dietary habits (105). They found that GI was positively associated
with BMI, fasting blood glucose, and glycated hemoglobin while GL was independently
negatively associated with HDL and positively associated with fasting triacylglycerol and
glucose (105). Negative correlation between GL and HDL was a noticeable finding, but it
was a snap-shot observation from Japanese female farmers, therefore further long-term
observation may be needed.
With the stream of whole grains study, cross-sectional study of Jenson et al.
examined the association between whole grains, bran, and germ in relation to
homocystein and markers of glycemic control, lipids, and inflammation among healthy
sub-samples (n = 938) from the Health Professionals Follow-up Study and the Nurses’
Health Study II and found that whole grains intake was inversely associated with
homocystein, total cholesterol, the most strongly with glycemic control, but not
associated with markers of inflammation (106).
However, Qi et al. found a significant association between whole grains, GI, and
GL and plasma biomarkers of inflammation among 902 diabetic women in the same
study group, the Nurses’ Health Study (107). In a meta-analysis of randomized controlled
trials, Brand-Miller et al. searched 14 studies comprising 356 subjects and all were
parallel experimental design of 12 days’ to 12 months’ duration with modification of at
least two meals per day (108). The result was that low-GI diets reduced Hemoglobin A1c
by 43% indicating the effect of low-GI diets was small but clinically useful for the
glycemic control in patients with diabetes (108). Table 3 summarized population-based
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prospective and cross-sectional studies and one meta-analysis of clinical trials.
Table 3. Reports from prospective cohort & cross-sectional studies examining the
relationship between dietary glycemic index & glycemic load and chronic diseases
Reference
Salmeron,
1997
(18)

Study
design
Cohort
(6 yrs) in
men

N

Disease state

42759

Type 2
diabetes

Difference in
parameter
Quintiles in
GI

Association RR
or OR
GI, RR 1.37
(1.02-1.83)
Comb, RR 2.17
(1.04-4.54)

65173

Type 2
diabetes

Quintiles in
GI

RR 1.37 (1.091.71)

Quintiles in
whole grains

RR 0.62 for
whole grains
RR 1.31 for
refined grains
RR 0.57 (0.480.69)

Salmeron,
1997
(19)
Liu, 2000
(103)

Cohort
(6 yrs) in
women
Cohort
(10 yrs) in
women

Fung ,
2000
(21)

Prospecti
ve cohort
(≥12 yrs) in
men

42898

Type 2
diabetes

Quintiles in
whole-grain
intake

Schulze,
2004
(26)

Prospecti
ve cohort
(for 8 yrs)
in young
women
Framing
ham
offspring
cohort
(1991-95)

91249

Type 2
diabetes

Quintiles in
GI, GL, fiber

RR GI
1.59(1.212.10)/fiber 0.64
(0.48-0.86)

2834

Insulin
resistance &
metabolic
syndrome

Quintiles in
GI, GL, wholegrain, fiber

OR; cereal fiber
0.62
whole-grain
0.67, GI 1.41

Cohort
(19811984) in
older adult

535

Metabolic
syndrome,
CVD, mortality
from CVD

Quartiles in
whole-grain

whole-grain
OR 0.46 for
metabolic
RR 0.48 for
CVD mortality

1354

Type 2
diabetes & CVD

Jenson,
2006
(106)

Crosssectional
study in
Japanese
women
Crosssectional
study

938

Diabetes,
inflammation,
IHD

Qi, 2006
(107)

Cohort
in women

902

Mckeown,
2004
(104)

Sahyoun,
2006
(24)

Murakami,
2006
(105)

BrandMiller,
2003
(108)

Metaanalysis of
randomized
controlled
trials

75521

356
(14
trials)

Diabetes

Diabetes
inflammation

Diabetes

Quintiles in
homocystein,
plasma markers
Quintiles in
GI

HbA1c ↓ 40%
by low GI diet

Note
Significance for 5th
quintile of GI after
adjusting fiber
Highly significant in
combination of GL & fiber
Significance for 5th
quintile of GI after
adjusting fiber
More significance in
women BMI > 25
Significance for 5th
quintile of whole-grain
intake after adjusting age;
inverse association-can be
modified by BMI
GI – significant positive
Fiber – inverse assoc.
GL – no significant
(RR; 1, 1.31, 1.20, 1.14,
and 1.33, p=0.21)
Significance for 5th
quintile of GI, wholegrain, largely from cereal
fiber. Whole-grain intake↓
HOMA-IR & metabolic
syndrome
Significance for 4th
quartile of whole-grain
intake & refined grains

GI & GL are
independently correlated
with several metabolic
risk factors (GL inversely
associated with HDL)
Whole grain diet lower
risk of diabetes, heart
disease, but not
inflammation
Whole grains and low
GI diet reduce the risk of
systemic inflammation in
type 2 diabetes women
The use of Low GI diet
to improve glycemic
control in practice – the
effect was samall, but
useful in clinical setting.
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There were also contradicting findings that did not support the hypothesis that a
high-GI leads to diabetes. In the Iowa Women’s Health Study by Meyer et al. (102) and
the Atherosclerosis Risk in Communities Study by Stevens et al. (109), neither GI nor GL
showed any association with diabetes risk.
In conclusion, although a few studies have reported contradicting findings,
substantial evidence from population-based cohort studies has accumulated showing that
the long-term consumption of high GI and GL diet can adversely affect metabolism and
health (110). Cordain et al pointed out that chronic exposure in hyperglycemia and
hyperinsulinemia induced by high GL diet may promote insulin resistance and the
metabolic syndrome (110).

Link between glycemic index / glycemic load
and Alzheimer’s disease via its role in insulin resistance
and type II diabetes
Diabetes and insulin resistance (hyperinsulinemia) have been associated with an
increased risk of AD in clinical experiments, population-based cross-sectional study or
cohort study, as well as animal studies. Dietary intake of foods containing carbohydrates
that are rapidly absorbed from the gastrointestinal tract thereby increase blood glucose
levels and affect insulin concentrations in terms of high in GI and GL have been
associated with an increased risk of type II diabetes and metabolic syndrome through
insulin resistance and hyperinsulinemia.
Syllogistically the hypothesis that GI and GL may be associated with risk of AD
via insulin resistance can be made. The growing body of study has related nutrients to
cognitive decline and AD through epidemiological studies, particularly focusing on
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individual dietary nutrients such as homocystein-related B vitamins (folate, vitamin
B6,12), antioxidants (vitamin E, C, carotenoids, flavonoids, enzymatic cofactors), dietary
lipids (poly-, mono-unsaturated fat, and DHA (mainly fish), EHA) (35). However, there
has been little invested in the research for this association between GI & GL and AD.
Only two studies were found: one large cohort and one small clinical trial, but they
had a conflicting result. In the clinical trial, Greenwood et al. examined the impact of
acute carbohydrate consumption on memory impairment among 19 adults with type II
diabetes and they found that poorer glycemic control is associated with lower
performance on tests of declarative memory and acute ingestion of high GI foods further
contributed to the underlying memory impairment (111). Contrary, in the cohort study,
Luchshinger et al. explored the relation of GL with AD risk among 939 elderly people
without dementia for 6.3 years, but the result was that higher risk of AD was associated
with only total calories, not GL (37).
Prospective cohort studies from the Cache County Study on Memory, Health and
Aging, CHAP study, Kame project, and WHICAP study focused on the relation between
food groups or dietary patterns and cognitive decline and dementia (37). Not all (CHAP
study found no fruit-cognitive change association), but the results from three large
prospective cohort studies provided evidence for the inverse association between fruits,
vegetables and fish intake and risk of AD or MeDi diet and risk of AD (39, 41).
Interestingly, carbohydrate foods of inversely associated with risk of AD and the
carbohydrate components in diet (MeDi) are both mutual in low or medium GI/GL foods.
GI & GL have been used as a tool to measure physiological effect of carbohydrates
intake related to insulin resistance and DM. Insulin resistance and type II diabetes have
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been linked with increased risk of AD with substantial evidences. However association
between AD and insulin resistance or AD and type II diabetes were not always provided
from prospective cohort studies and clinical trials. Similarly, with existing controversies
and much debate among researchers, the findings of association between GI/ GL and
insulin resistance and DM have been outnumbered non-significant ones. Based on this
premise, GI/GL can be linked to the risk of AD and a hypothesis that low GI & GL diet is
associated with reduced risk of AD can be established. If the finding of this research
provides evidence of hypothesized association, dietary GI/GL may contribute an
important role in preventing or delaying cognitive impairment and AD.

34
RESEARCH OBJECTIVE
The objective of this study is to find a possible relationship between dietary
glycemic load intake and Alzheimer’s disease based on the premise as follows:
association between high glycemic index and glycemic load and the risk of insulin
resistance and type II diabetes, and association between insulin resistance and type II
diabetes and the risk of Alzheimer’s disease. Therefore, the hypothesis to be tested is that
high glycemic load diet is associated with increased risk of incident Alzheimer’s disease.
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SUBJECTS AND METHODS

Study participants
The Cache County Study on Memory, Health and Aging is a population-based,
prospective cohort study of the prevalence and incidence of dementia and Alzheimer’s
disease (AD) among the Cache County elderly people of Northern Utah, was established
in 1994, and has been funded by the United States National Institute on Aging (3, 41).
The study has been collaborated with Duke University at the beginning, John Hopkins
University, Harvard University, the University of Washington, Brigham Young University,
and the University of Utah later (3).
There were 5,092 participants (ninety percent) among 5,677 Cache County
residents aged sixty five years or older (mean age, 74.9 years for men and 76.5 years for
women) at the baseline examination (3, 41, 62) . Approximately 90 percent of elderly
Cache County people are members of The Church of Jesus Christ of Latter-day Saints
(LDS or Mormon) (3). Their religion forbids smoking, drinking alcohol, and caffeinated
drink such as tea and coffee. This life style may contribute to the health effects thereby a
long-life span. Because of a long-life span compared to other states, rates of AD are
projected to rise 127 percent by 2025 (3).
The participants completed the baseline interview regarding demographic
characteristics, medical history, occupational history, family history of dementia, diet,
smoking, alcohol use, and other lifestyle factors between 1995 and 1996 (3, 41). The
APOE ε-4 alleles genotyping was examined by a cheek-swab DNA sample from the
participants (41).
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Demographic characteristics of participants including age, gender, body max index
(BMI = Weight in kg/ (Height in meter)2), diabetes, myocardial infarction (MI), stroke,
education, physical activity (indicator of moderate physical activity), smoking, alcohol
use, and APOE ε-4 genotype obtained from the baseline interview were used as nondietary covariates in this data analysis.

Diagnosis of dementia and Alzheimer’s disease
Cognitive screening was assessed in the baseline interview (1995) and four followup screenings were conducted during 1996-1997 (Telephone) 1998-1999 (Wave 2), 20022003 (Wave 3), and 2006-2007 (Wave 4) (3, 62). The Modified Mini-mental State
Examination (3MS) was used to assess cognitive function and to screen for dementia (41).
If participants scored below a sensory adjusted cut-point at any time points of screening,
then all suspicious cases of dementia went on the sequential multi-stage screening to
diagnose prevalence and incidence of dementia and AD. Final clinical diagnoses for
dementia and AD were appointed by consensus conferences including geropsychiatrists,
neuropsychologists, a neurologist, and a neuroscientist (3). Incidence of AD was
measured as new cases of AD during the time period of wave 2, wave 3, and wave 4
among participant without dementia and AD at the baseline. The data for the incident of
AD we used was collected after the baseline screening to the time point somewhere
between wave 3 and wave 4.

Diet assessment
At the baseline examination, 3831 dietary Food Frequency Questionnaires (FFQ)
were collected among 5,092 participants because 355 people who were scored below the
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cutoff for the 3MS at the baseline cognitive screening were not received FFQ and 3,831
people among remaining 4,737 participants returned the FFQ. Of those, 3,634 persons
remained after excluding 197 persons who reported implausible dietary data (daily
calorie intake less than 500 kcal and more than 5000 kcal), diagnosed as an additional
prevalent dementia after clinical assessment, and two persons who did not participate the
baseline dementia screening (41). The final sample data of 3634 participants including
1,564 men and 2,070 women from the baseline examination were used to estimate usual
dietary intake of carbohydrates in terms of GI and GL and other macro-nutrients
characteristics.
Assessment of usual daily dietary intake was examined with self-reported a 142
food item Food Frequency Questionnaire (FFQ) as shown in Appendix. FFQ used in the
Cache County Study was based on the semi quantitative FFQ developed by the Nurses’
Health Study (NHS). The reproducibility of the NHS FFQ was evaluated among 38,121
elderly women aged from fifty five to sixty nine years in the Iowa Woman’s Health Study
by Munger et al. (41, 112).
The FFQ we used had 142 food items and a specified portion size for each food
item (e.g., 8oz. of skim milk). Some food items with ambiguous portion size or without
portion size were referred to the nutritional professionals and the registered dietitian (RD).
There were nine possible responses ranging from “NONE OR LESS THAN 1 PER MO.”
to “6 PER DAY.” Nutrient values for all food items in the baseline FFQ were derived
from the ESHA program, 1997 version.
Glycemic Index Table and a web site maintained by Sydney University were used
as primary sources to assign GI values to foods (91, 93). There are two GI values: one for
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glucose referenced and one for white bread referenced for each food. This study used
glucose referenced GI value. If food items were not in the GI tables, the method to
determine GI values for those food items were referred to the methodology created by
Flood et al. Their article published in 2006 described nine-steps of an algorithm linking
GI values to foods, but this study set the seven steps based on their methods (Figure 2)
(95).

Carb: carbohydrates
142 Food list
from FFQ

1. Direct link to GI table

If not
2. Impute GI value of
closely related foods

4. Use weighted mean of
GI’s ingredients if mixed
foods

5. Impute GI value from
top 90% Carb
contributors from Flood’s
table if food item is
linked to them

If not
3. Impute vegetable
mean if it is vegetable

6. Impute 50 if not linked to
any food item, but has Carb

If not
7. Impute 0 if food item
have no Carb

Figure 2. Seven steps of algorithm in linking GI values (cited from Flood, 2006 (95))
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The ESHA program had a nutrient database per 100 grams of food, so the gram of
carbohydrate for each food item (Carb) was calculated as follows: CHO = (total gram of
each food/ a portion on FFQ x carbohydrate content per 100 gram of each food from
ESHA data base)÷100. Other nutrients for each food item per portion were calculated by
the same way. And then, nutrient intakes were computed by multiplying the frequency
response by the nutrient content of the specified portion sizes.
A separate table for the Ready to Eat Cold Cereal (RTECC) was made because
RTECC had a great variety in types as well as in amounts of carbohydrates. RETCC table
contained 62 different types of cereal list and nutrient values were also derived from the
1997 version of ESHA program. GI value for each cereal was assigned from the
Glycemic Index Table and if there is no GI value for certain type of cereal, the GI value
of the cereal with closed amounts in carbohydrate, fiber, and sugar content was given.
And then this table was merged into the original Food table.
Finally two tables, food table including nutrients content of 142 food item per 100g
as well as GI value for the each food item and data base input file which had total gram
of carbohydrates of 142 food items consumed by participants per day, were prepared to
calculate total glycemic load (GL) per day (dietary GL intake per day). We used the
FoodCalc program written by Jasper Lauritsen to make cross these tables and to calculate
total dietary GL intake for 3634 participants (113).
GL for each food item in each participant was calculated by multiplying the final
grams of carbohydrate from the carbohydrate content for each portion of food times the
average number of servings of that food per day by the food’s GI value. Total dietary GL
for each participant then was produced by summing the GL scores over all food items.
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Statistical methods
Statistical analyses were conducted with SPSS 15.0 for Window software program.
Descriptive statistic analysis was used to see normality of the distribution of total
glycemic load (GL), the demographic and nutrient characteristics of participants, and
correlations of GL with other dietary variables at the baseline. The demographic, clinical,
and dietary characteristics were crossed by gender and then demographic and clinical
characteristics were crossed by kcal adjusted GL quintiles separately in gender. Energy
adjusted GL was calculated as follows:
Kcal adjusted GL = (total GL/total kcal) x 1000 = GL/1000kcal
We analyzed most of data separately by gender because men and women had very
different characteristics in many aspects.
Continuous variables such as age (years), BMI, total kcals, total carbohydrates (g),
total fiber (g), total sugar (g), total protein (g), and total fat (g) were compared using oneway ANOVA test, and categorical variables such as dementia (all dementia types, 0/1
indicator), gender, education (< high school or > high school), diabetes (yes or no),
smoking (yes or no), alcohol use (yes or no), APOE ε-4 alleles (0 – 2 copies), and
moderate physical activity (3 levels: everyday or 2-6 times per week, 1-4 times per week,
and rare) were compared using chi-squared test.
Distribution of diabetes crossed GL quintiles stratified by gender as well as
distribution of dementia among diabetes was examined to look at whether diabetes is a
confounding factor or not. Distribution of dementia among GL quintiles stratified by
gender and diabetes was also examined to look at the association between diabetes,
dementia, and GL. And then, the same test was conducted after exclusion of 464 diabetes
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cases by assuming diabetes as a confounder. Finally the same procedure, but with
different GL categories (dichotomy): the first group for the first quintile and the second
group for the upper groups (Quintiles 2-5), was conducted to examine the association
between dietary lower GL intake and the risk of dementia.
Survival analysis: Cox proportional hazards regression models were used in
univariate and multivariate analyses exploring the relation of GL with AD. The time to
event variable represents time from the baseline dietary assessment to incident AD. We
used a time variable with the time of age onset. Persons who were lost to follow-up or did
not develop dementia were censored at the last time of follow up (code = 0). Persons who
developed dementias coded according to the type of dementia (1 = pure AD, 2 = primary
VaD with secondary AD, 3 = VaD: vascular dementia, and 4 = other types of dementia).
Estimated hazard ratios (HRs) for AD with the dichotomy of GL using the lower group
(the first quintile group, 20%) as the reference was used to compare with upper groups
(quintile 2 – 5, 80%).
The study used the univariate and multivariate analyses for two models: one (I) for
the raw model and one (II) adjusted for covariates including education, MI, stroke, BMI,
physical activity, smoking, alcohol, APOE ε-4 alleles, and multi-vitamins use. Genders
were split before running Cox hazard regression models. To detect confounding factors
among nutritious factors, at first, Cox hazard regression was used to compare hazard ratio
between nutritious factors and incident AD and an adjustment technique was used and the
results from adjusted estimate were compared to the crude result.
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RESULTS
Frequency distribution in the histogram from the descriptive analysis of glycemic
load (GL) showed right skewness in Figure 3. After adjusted energy, the distribution of
GL became normal (skewness = 0.096) as shown in Figure 4.
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Figure 3. Frequency distribution in total glycemic load before energy adjustment
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Figure 4. Frequency distribution in total glycemic load after energy adjustment
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Table 4 includes overall demographic and clinical characteristics of valid
participants at baseline by gender before energy adjustment. Of the total participants,
approximately 57 percent were female and mean age for men and women was 74.2 years
and 75.0 years. Mean BMI for men and women were 26.4 and 26.1 which both belong to
over-weight category (BMI ≥ 25: over-weight, BMI ≥ 30: obese). There is no gender
difference in mean BMI. The majority of participants had attained at least a high school
education or higher (81.5 percent for men and 86.6 percent for women) and more women
were educated at the level of high school or greater. Seventy-two percent of men and 65.5
percent of women had a moderate physical activity every day or two to six times per
week, so more men were appeared physically active. Over 90 percent of women reported
never having smoked cigarettes and consumed alcohol, but men reported that over 70
percent never drank alcohol and over 60 percent never smoked cigarettes. Self-reported
diabetes was 14 percent for men and 12 percent for women. Additional characteristics of
participant by gender are listed in Table 4.
Table 5 includes characteristics of dietary and macro-nutrients obtained from the
baseline FFQ. Mean total GL per day for men and women were 147 (SD = 60.1) and 138
(SD = 58.3). Energy adjusted GL was 72.1 (SD = 11.4) for men and 73.8 (SD = 11.4) for
women. Mean total GL intake was greater in men, but it was greater in women after
energy adjustment. Mean total kcals for men and women were 2048 (SD = 785.6) kcals
and 1882 (SD = 763.9) kcals. Other characteristics such as carbohydrate, fiber, sugar,
protein, fat, and use of multi-vitamins are listed in Table 5. Noticeable thing is overall
macro-nutrients mean intake was higher in men but fiber mean intake was the same in
both men and women.

44
Table 4. Demographic and clinical characteristics of baseline
in the Cache County Study on Memory, Health, and Aging by gender 1
Characteristics
Male
Female
(n = 1564)
(n = 2070)
Total glycemic load**
Glycemic load/1000 kcals**
Age**
BMI (kg/m2)*
Dementia (%)3
Diabetes (%)*
MI (%)**
Stroke (%)

Yes
No
Yes
No
Yes
No
Probable
Uncertain
No

147.2 ± 60.12
72.1 ± 11.4
74.2 ± 6.5

138.0 ± 58.3
73.8 ± 11.4
75.0 ± 6.8

26.4 ± 3.9
8.1
91.9
14.0
86.0
17.5
82.5
3.7
0.8
95.6

26.1 ± 4.8
9.3
90.7
12.0
88.0
8.8
91.2
3.0
0.5
96.4

81.5
18.5

86.6
13.4

76.2
12.8
11.0
65.2
31.5
3.3
72.7
20.8
6.5
67.7
29.2
3.1

65.5
17.5
17.0
93.1
5.5
1.4
92.5
5.1
2.3
69.2
29.0
1.9

Education (%)**
> High School
< High School
Physical Activity (%) **
Everyday or 2-6x/week
1-4 times/ month
Rare
Smoking (%) **

Never
Former
Current

Use Alcohol (%) **

Never
Former
Current

APOE ε-4 alelles

0 copy
1 copy
2 copies

1

Distribution of demographic and clinical covariates of baseline
population by gender
2

Mean ± standard deviation (SD)
** Significant difference between geder, p < 0.000
* Significant difference between geder, p < 0.05
3
Dementia = Incident dementia between wave 3 and 4, not prevalent dementia
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Table 5. Dietary and macro-nutrients characteristics of baseline
in the Cache County Study on Memory, Health, and Aging by gender 1
Dietary Characteristics
Total kcals*
Total carbohydrates*
Total fiber
Total sugar*
Total protein*
Total fat*
Total glycemic load*
Glycemic load/1000 kcals*
Use Multi-Vitamins (%)*
Yes
No

Male
(n = 1564)
2048.8 ± 785.62
268.3 ± 106.0
19.0 ± 9.2
136.8 ± 63.1
87.8 ± 35.6
74.0 ± 34.9
147.2 ± 60.1
72.1 ± 11.4

Female
(n = 2070)
1882 ± 763.9
255.1 ± 106.8
19.6 ± 10.2
129.3 ± 63.5
82.9 ± 37.1
64.2 ± 31.9
138.0 ± 58.3
73.8 ± 11.4

38.6
61.4

45.8
54.2

1

Distribution of dietary covariates of baseline population by gender
Mean ± stan between gender, p < standard deviation (SD), all macro-nutrients are in gram
* Significant difference 0.000 except Total fiaber (p=0.07)
2

The range of correlations was greatly changed between GL and other dietary
characteristics after energy adjustment, but GL was still correlated with carbohydrates
and sugar intake, moderately correlated with fiber, and negatively correlated with protein
and fat intake in Table 6 and Table 7. Correlation between energy (kcals) and other
macro-nutrients ranging from 0.45 to 0.90 were not significantly changed after energy
adjustment.
Table 8 and Table 9 separately show the demographic and clinical characteristics
among energy adjusted GL quintiles by gender. In men, GL was significantly associated
(p<0.000) with diabetes, smoking, and alcohol use, and moderately associated (p<0.05)
with education and physical activity. Other covariates including age, BMI, dementia, MI,
stroke, and APOE ε-4 alleles were not associated with GL. In women, GL was
significantly associated with diabetes, and alcohol use, moderately associated with age,
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BMI, and smoking, not associated with other covariates.

Table 6. Correlations of glycemic load (GL) with other dietary variables
GL

Kcals

Protein

Carb

Fiber

Sugar

Fat

GL
1
Kcals
.919(**)
1
Protein
.683(**) .869(**)
1
Carbohydrates
.984(**) .927(**) .718(**)
1
Fiber
.698(**) .687(**) .612(**) .779(**)
1
Sugar
.865(**) .792(**) .580(**) .902(**) .676(**)
1
Fat
.728(**) .908(**) .779(**) .713(**) .454(**) .561(**)
** Correlation is significant at the 0.01 level (2-tailed). Carb=carbohydrates

1

Table 7.Correlations of energy-adjusted glycemic load with other dietary variables
GL
Kcals
Protein
Carbohydrates
Fiber
Sugar
Fat

GL
1
-.092(**)
-.349(**)
.220(**)
.086(**)
.241(**)
-.327(**)

Kcals

Protein

Carb

Fiber

Sugar

Fat

1
.868(**)
.927(**)
.693(**)
.789(**)
.907(**)

1
.713(**)
.616(**)
.570(**)
.779(**)

1
.779(**)
.898(**)
.712(**)

1
.664(**)
.463(**)

1
.562(**)

1

** Correlation is significant at the 0.01 level (2-tailed). Carb=carbohydrates

In current alcohol users in both men and women, percentage of people in current
use was notably decreased with increasing quintiles. On the other hand, never user
showed opposite direction in Table 8 and Table 9. A similar trend was appeared in the
current smokers particularly in men. In short, current alcohol user and smoker had the
lowest GL intake in both genders.
Table 10 and Table 11 show diabetes as a confounder in the relation between GL
and AD through diabetes distribution among GL quintiles and dementia rates among
diabetes. The percentage of diabetes in the lowest quintile (Q1) over the highest quintile
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(Q2) was almost two times in men (21% vs. 13.6%) and greater than two times in women
(18.4% vs. 8.2%) in Table 10. Among non-diabetics, overall percentage increased with
ascending GL quintiles. People with diabetes had a higher percentage of dementia
compared to non-diabetes in Table 11. Our previous finding in the Cache County study
showed that diabetes at the baseline was associated with 4 times greater risk for
developing incident AD among men (RR=4.05, 95% CI:1.84-8.65) than non-diabetics,
but not in women from the data of W2 observation (62). Thus, this result indicated that
diabetes is problematic factor to estimate people’s usual carbohydrate intake as well as to
examine the association between GL and AD.
Diabetes was tested by cross-tabulating dementia distribution among GL quintiles
by gender and diabetes status because the observed association between GL and dementia
(no association in Table 8 and 9) may be affected by diabetes (changing their diet as diet
treatment). The effect of diabetes may also be appeared differently between male and
female. As depicted in Table 12, percentage of dementia in the fifth quintile was appeared
twice of the percentage of the first quintile in non-diabetic men featuring like a dose and
response-effect; however women had a U-shape in the distribution of percentage of
dementia among GL quintiles in non-diabetics. There might be a possibility association
of dementia related to GL in non-diabetic men, but p-value was not significant (p-value <
0.05).
Because of possible dose- response effect shown in non-diabetic men in Table 12,
we had an additional test by grouping GL quintiles into a dichotomy: the first quintile
(Q1, 20%) versus upper level quintiles (80%, Q2 – Q5). The result showed that dementia
was significantly associated with GL in non-diabetic men (p = 0.019) in Table 13.
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Table 8. Demographic and clinical characteristics among energy-adjusted
glycemic load quintiles in men
Glycemic Load Quintiles
1
2
3
4
Characteristics
(n=352)
(n=327)
(n=306)
(n=295)
Glycemic Load
57.2 ±.6.1 67.3 ± 1.7 72.8 ± 1.6 78.3 ± 1.8
Age
73.6 ± 6.4 74.0 ± 6.6 74.6 ± 6.7 74.3 ± 6.2
BMI (kg/m2)
Dementia (%)

Yes
No

Education (%)*
> High School
< High School
Physical Activity (%) *
Everyday or 2- 6x/week
1-4 times/ month
Rare

Diabetes (%) **
MI (%)

Yes
No
Yes
No

5
(n=284)
88.7± 6.2
74.7 ± 6.7

26.9 ± 4.4
6.0
94

26.4 ± 3.5
7.0
93

26.2 ± 4.0
8.8
91.2

26.2 ± 3.4
10.2
89.8

26.2 ± 3.9
8.8
91.2

79.5
20.5

81
19.0

76.5
23.5

87.8
12.2

83.5
16.5

69.8
16.1
14.1
21.0
79.0
14.0
86.0

76.6
14
9.3
9.5
90.5
16.0
84.0

82.2
8.3
9.6
11.9
88.1
16.8
83.2

77.6
14.1
8.3
13.1
86.9
20.8
79.2

75.4
11
13.5
13.6
86.4
21.1
78.9

5.5
1.2
93.3

4.9
0.3
94.8

2.0
1.0
97.0

2.4
1.0
96.5

2.9
0.4
96.7

54.0
37.4
8.6

64.2
32.1
3.7

70.0
29.0
1.0

72.2
26.8
1.0

68.1
30.8
1.1

61.5
21.7
16.8
67.7
30.0
2.3

70.2
22.4
7.4
71.6
26.0
2.4

74.3
21.4
4.3
70.8
27.2
2.0

81.2
17.5
1.4
63.5
31.1
5.5

79.0
20.6
0.4
64.5
31.9
3.5

Stroke (%)
Probable
Uncertain
No
Smoking (%) **
Never
Former
Current
Use Alcohol (%) **
Never
Former
Current
APOE ε-4 alelles 0copy

1 copy
2 copies

* p<0.05, ** p<0.000, Mean ± SD (all such values)
Physical Activity is moderate activity
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Table 9. Demographic and clinical
glycemic load quintiles in women
Characteristics
1
(n=374)
Glycemic Load range
57.8 ±.6.2
Age *
74.4 ± 6.7
BMI (kg/m2) *
26.5 ± 5.1
12.3
Dementia (%)
Yes
87.7
No
Education (%)
84.8
> High School
15.2
< High School
Physical Activity (%)
65.5
Everyday or 2-6x/week
16.6
1-4 times/ month
18.0
Rare
Diabetes (%) **
18.4
Yes
81.6
No
MI (%)
10.3
Yes
89.7
No
2.7
Stroke (%)
Probable
0.8
Uncertain
96.5
No
90.1
Smoking (%) *
Never
8.0
Former
1.9
Current
Use Alcohol (%) **
88.5
Never
7.2
Former
4.3
Current
APOEε-4alelles (%) 0copy

1 copy
2 copies

68.5
30.5
1.1

characteristics among energy-adjusted
Glycemic Load Quintiles
2
3
4
(n=400)
(n=422)
(n=432)
67.6± 1.6
72.7± 1.6
78.5± 1.8

5
(n=442)
89.5 ± 6.7

74.7 ± 6.7
26.1 ± 5.0
8.5
91.5

75.1 ± 6.6
26.2 ± 4.6
6.9
93.1

74.5 ± 6.6
26.1 ± 4.8
9.0
91.0

76.2 ± 7.0
25.4 ± 4.6
10.0
90.0

87.8
12.3

86.7
13.3

86.3
13.7

87.3
12.7

61.4
20.2
18.4

70.9
16.0
13.1

66.9
15.1
18.0

62.8
19.4
17.8

12.0
88.0

11.2
88.8

10.9
89.1

8.2
91.8

8.0

8.2

9.3

8.5

92.0
2.3
0.0
97.7
91.0
6.0
3.0

91.8
3.6
0.7
95.6
94.0
4.8
1.2

90.7
4.2
0.2
95.6
93.5
5.6
0.9

91.5
2.3
0.9
96.8
96.1
3.6
0.2

91.0
5.0
4.0

92.6
4.5
2.9

93.5
6.0
0.5

96.4
3.2
0.5

70.7
28.3
1.0

65.2
31.9
2.9

68.9
28.3
2.8

72.5
26.1
1.4

* p<0.05, ** p<0.000, mean ± SD (all such values)
Physical Activity is moderate activities.
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Table 10. Diabetes distribution among glycemic load quintiles1
stratified by gender
Glycemic Load Quintiles
Gender
1
2
3
4
5
Diabetes
Total Count
348.0 326.0 303.0 289.0 280.0
Male**
No (%)
79.0
90.5
88.1
86.9
86.4
Yes (%)
21.0
9.5
11.9
13.1
13.6
Female**

1

Total Count
No (%)
Yes (%)

374.0
81.6
18.4

399.0
88.0
12.0

418.0
88.8
11.2

430.0
89.1
10.9

441.0
91.8
8.2

Total
1546

2062

Energy adjusted glycemic load, ** p < 0.000

Table 11. Dementia distribution among diabetes stratified by gender
Diabetes
Non-diabetes
Male
Dementia (%)
10.35
6.5
Non dementia (%)
89.65
94.5
Female
Dementia (%)
11.2
10.25
Non dementia (%)
88.8
89.75

Table 12. Distribution of dementia among kcal adjusted
glycemic load quintiles by gender and diabetes
Gender
Quintiles of Kcal-adjusted Glycemic Load
1
2
3
4
5
Diabetes
Male

No Diabetes

(n=1564)

Diabetes
(n=216,14% )

Female

No Diabetes

Dementia (%)
Non-Dementia
Dementia
Non-Dementia
Dementia

Non-Dementia
Dementia
(n=2070)
Diabetes
Non-Dementia
(n=247, 12%)
Dementia
All p-values were not significant

(n=726) (n=721) (n=728) (n=727)

(n=726)

95.6
4.4
87.7
12.3

92.2
7.8
100
0.0

91.4
8.6
88.9
11.1

90.8
9.2
86.8
13.2

90.9
9.1
92.1
7.9

88.2
11.8
85.5
14.5

91.7
8.3
89.6
10.4

93.3
6.7
91.5
8.5

90.9
9.1
93.6
6.4

89.6
10.4
94.4
5.6
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Table 13. Dementia distribution comparison across gender stratified
by diabetes among energy adjusted GL quintile 1 vs. quintile 2 - 5
Gender
GL Quintile 1 vs. GL Quintile 2 - 5
Diabetes

p-value1

Q1
(n=722)
95.6
4.4

Q2 - Q5
(n=2912)
91.4
8.6

Diabetes Non-Dementia
(n=216,14% )
Dementia

87.7
12.3

91.6
8.4

0.356

Non-Diabetes Non-Dementia
Female
Dementia
(n=2070)

88.2
11.8

91.3
8.7

0.085

Diabetes Non-Dementia
(n=247,12%)
Dementia

85.5
14.5

92.1
7.9

0.115

Dementia (%)
Non-Diabetes Non-Dementia
Male
(n=1564)
*Dementia

0.019

1

p-value = Pearson Chi-Square 2-sided p-value
* significant, if p-value < 0.05

Therefore, we considered diabetes as a confounding factor in association between
GL and dementia because diabetes was associated with GL in both genders and with
incident AD in men. Furthermore, Using FFQ from diabetics was not appropriate to
measure usual dietary carbohydrate intake because diabetic patients changed their diet to
treat the disease. Thus, 464 diabetics from the valid FFQ (n=3,634) were excluded and
remained 3,170. After exclusion of diabetes, Table 14 shows the significant positive
association (p=0.014) between GL and dementia in men, not for women (p=0.087).
Cox proportional hazards regression models were used to explore the relation of
GL with pure incident AD. Overall, 273 (8.6%) participants among 3,170 participants
experienced development of incident dementia; AD developed in 180 (5.7% of sample
population, 65.9% of total dementia) of these people during about 10 years observation.
In Model I, energy adjusted GL categorized as dichotomy: upper 80% higher GL
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group vs. 20% lowest GL group using the first quintile group as a reference was not
associated with incident AD in men (HR for AD =1.33; 95% CI: 0.63, 2.81; p = 0.456)
while inversely associated with incident AD in women (HR for AD = 0.62; 95% CI: 0.4,
0.95; p = 0.027) (Table 15).

Table 14. Dementia dstribution cmparison across gnder
by eergy adjusted GL qintile 1 vs. quintile 2 - 5
after eclusion of diabetes (n=464)
Gender
GL Quintile 1 vs. GL Quintile 2 - 5
Male
(n=1348)

Female
(n=1823)

Dementia
Count
No Dementia (%)
Dementia (%)*

Q1
279
95.7
4.3

Q2 - Q5
1068
91.3
8.7

Count
No Dementia (%)
Dementia (%)

305
88.2
11.8

1518
91.3
8.7

p-value1

0.014

0.087

p-value 1 = Pearson Chi-Square 2-sided p-value
* significant, if p-value < 0.05

Table 15. Cox proportional hazard models for AD by GL
GL Q2-5 vs. Q1
At Risk, n
AD (%)
HR (95% CI)
Model
1

I
Male
Female
II2
Male
Female
1
2

1346
1820
1245
1632

p value

58 (4.3)
122 (6.7)

1 (reference)
1.33 (0.63-2.81)
0.62 (0.40-0.95)

0.456
0.027

56 (4.2)
106 (5.8)

1 (reference)
1.10 (0.5-2.39)
0.54(0.34-0.85)

0.817
0.007

is unadjusted raw model
is adjusted for education, MI, stroke, BMI, physical activity, smoking,

alcohol use, APOE ε-4 alleles, and multi-vitamins use
GL = Glycemic Load; HR = Hazard ratio; CI = Confidence interval
AD = Alzheimer's disease
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Survival function graphs from SPSS survival analysis show comparisons of survival
curves (incident AD curve) and hazard curves between low GL group (pattern 1, blue
line) and high GL group (pattern 2, green line) in Figure 5. In the survival curve, incident
AD appeared earlier in the higher GL intake group compared to the low GL intake group
in men but p-value was not significant while low GL intake group had earlier AD ageonset compared to the higher GL intake group in women with significant p-value. The
results were unchanged after addition of all non-nutrient covariates in Model II (Table
15).

Survival Function for patterns 1 - 2

Survival Function for patterns 1 - 2
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Figure 5. Survival & hazard curve (incident AD) comparison by gender (Model I)
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Mean intake of total kcal and macro-nutrients such as carbohydrates, fat, protein,
sugar, fiber, and saturated fat were compared by GL quintiles to examine a possibility of
confounding factors by nutritional factors in Table 16 and 17. The result was that the first
quintile group consumed the highest total kcal, protein, fat, SFA intake in women and the
highest protein, fat, SFA intake in men.
The analysis of distribution of smoking and alcohol use by GL quintiles to explore
the characteristics of the first quintile of GL intake showed that the number of current
smokers and alcohol users were the highest percentage in GL quintile 1 in men and in GL
quintile 1 and 2 in women in Table 18 - 21.

Tabel 16. Mean intake of kcal & macro-nutrients (gram) by GL quintiles in men
GL Q/ 1000 kcals
Kcal
Protein
Carb Fiber
Sugar Fat SFA
1
2107
102
229
17
115
88
31
2
2066
92
256
18
131
79
27
3
2135
90
282
20
143
77
27
4
2052
80
288
19
147
71
24
5
1922
69
301
19
162
56
19
Total mean
2060
87
270
19
138
75
26
GL=Glycemic Load, Carb=Carbohydrates, SFA=Saturated fatty acid, Trans FA=Trans fatty
acid

Table 17. Mean intake of kcal & macro-nutrients (gram) by GL quintiles in women
GL Q/ 1000 kcals
Kcal
Protein
Carb Fiber
Sugar Fat SFA
1
1983
102
222
18
109
80
28
2
1922
89
245
19
124
70
24
3
1934
85
260
20
133
67
23
4
1846
77
266
20
136
59
20
5
1758
64
279
20
147
50
17
Total mean
1882
82
256
19
131
64
22
GL=Glycemic Load, Carb=Carbohydrates, SFA=Saturated fatty acid, Trans FA=Trans fatty
acid
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Table 18. Smoking distribution by GL quintiles in men (n=1334)
GL per 1000 kcals Quintiles
1
2
3
4
143
184
185
182
Smoking
Never
(17%)
(21%)
(21%)
(21%)
107
100
Former
(25%)
(23%)
80 (19%) 69 (16%)
Current 27 (59%) 12 (26%)
3 (7%)
2 (4%)

5
167
(19%)
71 (17%)
2 (4%)

Chi2 test p-value, p<0.0000, Count (% within Ever/never smoker)

Table 19. Alcohol use distribution by GL quintiles in men (n=1337)
GL per 1000 kcals Quintiles
1
2
3
4
164
205
195
209
Alcohol use Never
(17%)
(21%)
(20%)
(22%)
Former 61 (23%) 66 (24%) 60 (22%) 41 (15%)
Current 53 (56%) 24 (25%) 13 (14%)
4 (4%)

5
198
(20%)
43 (16%)
1 (1%)

Chi2 test p-value, p<0.0000, Count (% within Ever/never drinker)

Table 20. Smoking distribution by GL quintiles in women (n=1814)
GL per 1000 kcals Quintiles
1
2
3
4
273
321
348
361
Smoking
Never
(16%)
(19%)
(21%)
(21%)
Former 24 (26%) 20 (22%) 18 (20%) 19 (21%)
Current 7 (27%)
10 (38%)
5 (19%)
4 (15%)

5
393
(23%)
11 (12%)
0

Chi2 test p-value, p<0.0030, Count (% within Ever/never smoker)

Table 21. Alcohol use distribution by GL quintiles in women (n=1819)
GL per 1000 kcals Quintiles
1
2
3
4
269
320
344
362
Alcohol use Never
(16%)
(19%)
(20%)
(21%)
Former 21 (24%) 17 (20%) 17 (20%) 21 (24%)
Current 14 (32%) 14 (32%) 12 (27%)
2 (5%)
Chi2 test p-value, p<0.0000, Count (% within Ever/never drinker)

5
394
(23%)
10 (12%)
2 (5%)
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Mean servings of food groups among GL quintile groups were revealed that the
first GL quintile group consumed higher intake in dairy foods, eggs, meats, fish, and
alcohol and lower intake fruits and soft drink in Table 22 (men) and 23 (women).
Vegetable intake was not associated with the low GL intake.
From Cox hazard regression analysis to detect a possible confounding among
nutritional factors, the associations appeared in total kcal quartile 4 in women and in total
SFA quartile 2 in women. After adjustment of those two nutritional factors and added
interaction term between GL and total kcal or SFA separately in Cox hazard regression
models (dependant variable: incident AD, independent variable: GL, adjusted covariate:
total kcal and SFA plus their interaction term). The result from model-adjusted SFA
showed the same result (no association in men and negative association in women) with
the crude model indicating no confounding while the model-adjusted total kcal showed a
different result (no association in both men and women) from the crude model indicating
a possible confounder. After adjustment of all other demographic covariates plus
controlling total kcal, no association between GL and incident AD became apparent in
women in Table 24.
Table 22. Mean servings of food groups by GL quintiles in men
GL Quintiles
Food Groups
1
2
3
4
5
p-value
Dairy
2.4
2.4
2.4
2.2
1.9
0.0030
Fruits
1.9
2.3
2.6
2.6
3.1
0.0000
Vegetables
3.4
3.3
3.6
3.2
3.1
0.0733
Eggs
0.6
0.4
0.3
0.2
0.2
0.0000
Meat
1.4
1.2
1
0.8
0.7
0.0000
Fish
0.3
0.2
0.2
0.2
0.2
0.0000
Soft Drink
0.4
0.6
0.6
0.8
1.2
0.0000
Alcohol
0.4
0.2
0.1
0
0
0.0000
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Table 23. Mean servings of food groups by GL quintiles in women
GL Quintiles
Food Groups
1
2
3
4
5
p-value
Dairy
2.3
2.4
2.3
2.1
1.7
0.0000
Fruits
2.2
2.5
2.8
3
3.3
0.0000
Vegetables
4.1
3.9
3.9
3.7
3.6
0.1072
Eggs
0.3
0.2
0.2
0.2
0.1
0.0000
Meat
1.4
1.1
1
0.8
0.6
0.0000
Fish
0.3
0.2
0.2
0.2
0.2
0.0000
Soft Drink
0.3
0.4
0.5
0.6
0.9
0.0000
Alcohol
0.5
0.4
0.3
0.3
0.3
0.0000

Table 24. Cox proportional hazard models for AD by GL after controlling
total kcal
GL Q2-5 vs. Q1
At Risk, n
AD (%)
HR (95% CI)
p value
Model
I1
Male
Female
II2
Male
Female
1
2

1346
1820
1245
1632

58 (4.3)
122 (6.7)

1 (reference)
0.967(0.28-3.40)
0.507 (0.25-1.01)

0.958
0.053

56 (4.2)
106 (5.8)

1 (reference)
2.899 (0.37-22.59)
0.703(0.26-1.92)

0.31
0.49

is raw model adjusted for total kcal + interaction with GL
is adjusted for education, MI, stroke, BMI, physical activity, smoking,

alcohol use, APOE ε-4 alleles, multi-vitamins use, and total kcal + interaction with GL
GL = Glycemic Load; HR = Hazard ratio; CI = Confidence interval
AD = Alzheimer's disease
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DISCUSSION
This study found that dietary energy-adjusted glycemic load (GL) was not
associated with the risk of Alzheimer’s disease when GL was categorized as dichotomy in
which the first quintile (20%) was compared with combined upper level of quintiles
(80%) and was used as the reference and total kcal was controlled as a confounder in
elderly 65 years and older who lived or have lived in the Cache County, Northern Utah.
These results included adjustment of covariates including education, MI, stroke, BMI,
physical activity, smoking, alcohol use, APOE ε-4 alleles, and multi-vitamins use.
The reason for categorizing GL into two groups (Q1 vs. Q2-5) was that the
percentage of dementia in non-diabetic men jumped from 4.4 % in Q1 to 7.8 % in Q2. It
was almost twice and then the rate kept constant ranging from 7.8 to 9.2 % throughout
Q5. Furthermore, after quintiles were transformed into this dichotomy, the association
between dementia and GL in non-diabetic men became significant. Thus we expected that
there might be a possible association between GL and AD in men. It was also thought
possible to link the previous finding by Charoonruk in our Cache County Study: diabetes
had 4 times greater risk for developing AD among men than non-diabetics (62).
The sample population of this study was started from people without diabetes and
examined the effect of GL by comparing low GL group with high GL group related to AD.
The reason of exclusion of diabetes from the sample population was that we wanted to
estimate usual carbohydrate intake pattern in terms of glycemic index (GI) and glycemic
load (GL), not affected or modified by other factors such as diabetes among baseline
participants. The dietary treatment for diabetes affected the amount of carbohydrates
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intake in both quality and quantity to control blood sugar, thus it consequently affected
GL intake thereby confounded our dietary assessment.
If the association between high GL and the risk of dementia in men we found in the
descriptive analysis appeared in Cox proportional hazard regression models in survival
analysis, it would be possible to relate the former finding between diabetes and incident
AD in men to the dietary characteristic of GL. However, our finding was no association
in both men and women.
A negative association between GL and incident AD was appeared in women
before we controlled total kcal as a confounder. We did not consider total kcal and other
macro-nutrients in the previous two models as covariates. We examined total kcal and
macro-nutrients to find why negative the finding was in women with very significant pvalue and what characteristics of the lowest quintile in women have. We found suspicious
characteristics of the first quintile of GL in women by mean distribution of macro
nutrients across quintiles. Noticeable thing was that the lowest quintile group consumed
the highest amount of kcal, protein, fat, and saturated fat. Men also had a similar pattern
(second high in kcal intake and the highest intake in protein and fat), but women showed
a prominent trend; total kcal, protein, and fat intake decrease with increasing GL whereas
carbohydrates, sugar, and fiber intake increase with GL. Women in Q1 group consumed
225 more kcals, 38g more proteins, and 30g more fat per day compared to the Q5 mean
intake. Table 17 summarized these characteristics.
After examination of possible confounding factors among total kcal and macronutrients, total kcal intake appeared as a possible confounder. As Cox hazard regression
model was controlled with total kcal and added interaction term with GL, no association
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was appeared in women. The significant level was closed to 0.05 and the confidence
interval included 1.0, thus there might be other confounding factors between GL and
incident AD. However, as the model adjusted for all other covariates including total kcal
plus interaction with GL, the result remained the same (no association in both men and
women) but the p-value became much greater in women thus underscoring the finding of
association.
Another thing to point out is dietary intake patterns of smoking and alcohol users.
Both smokers and alcohols user had the exact same pattern: never users had higher GL
intake, former users were middle, and current users had the lowest GL intake. Alcohol
contains no glucose and a minimal amount of carbohydrates, so GI = 0, at the same time,
GL = 0 because of zero GI value. Alcohol has 7 kcal per g and it is greater than
carbohydrates (4 kcals/ g) but has zero GL value.

Thus alcohol intake might partly

contribute to increase total kcal but decrease overall dietary GL intake. The life style of
alcohol users may also include smoking. Both habits tend to have an association with
dietary habits too. In other words, alcohols users tend to be more likely to smoke
compared with non-alcohol users and tend to have unhealthy diets such as eating less
fruits and vegetables.
Table 18– 23 may explain these complicated characteristics of the low GL quintile
group of people. The percentage of smoking and alcohol use was higher in the low GL
group and it was appeared clear in men due to more people in smoking and alcohol use
compared to women. In the mean serving intake of food groups, the low GL quintile
group consumed more dairy foods, eggs, meats, fish, and alcohol and less fruits and soft
drink. Vegetable intake was not associated with GL and appeared a similar number of
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servings throughout the quintiles.
To summarize, the low GL group had unique characteristics in life style factors,
macro-nutrients intake, and pattern of food use: higher percentage of smoking and
alcohol user in life style factors, high kcal, protein, fat, and saturated fat intake in macronutrients intake, and more specifically higher dairy, meat, eggs, alcohol intake and lower
fruits intake in the pattern of food use indicating that they more likely had unhealthy life
style and dietary pattern. The inverse relationship between GL and total kcal may partly
be explained by life style factors, particularly alcohol intake may have contributed to this
relationship because this group consisted of a large percentage of alcohol users and
alcohol had high kcal and zero GL value.
Last, there might be a possible reason for the no association in men. Men had a
consistent positive relationship between GL and dementia or AD, but significant level did
not support its association. Maybe, because of small number of sample size (n of AD =
58 among 1347 elderly men) partly due to a large number of exclusion for valid dietary
assessment. Thus, continued follow-up of both men and women is important.
To conclude, intakes of most nutrients tend to be positively correlated with total
energy intake (114), but carbohydrates intake in terms of GL was negatively correlated
with total kcal and other macro-nutrients such as protein and fat intake. Although GL was
adjusted for total kcal, total energy intake still affects the relation between GL and
incident AD. The life style factors such as smoking and alcohol use and their dietary
pattern also are associated with GL value. Therefore, GL alone may be of limited value to
examine the relationship between carbohydrates intake and AD. The pattern of food use
among carbohydrates containing foods may better reveal carbohydrates-intake related to
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incident AD.
Further research on total kcal intake related to incident dementia or AD among
people with or without APOE ε-4 alleles genotypes should be examined. Based on
previous finding in Cache County Study, that fruits, vegetables, and fish intake were
associated with reduced risk of cognitive decline, whole grain intake among total
carbohydrates intake related to incident dementia or AD is suggested as an important
topic for further exploration.
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CACHE COUNTY STUDY ON MEMORY IN AGING
NUTRITION QUESTIONNAIRE
Conducted by: Utah State University

Marking Instructions
Please follow these few simple rules in completing this questionnaire.
1.
2.
3.
4.
5.

Use only a pencil. (Please DO NOT use a pen)
Darken completely the circle of the answer you choose
Erase cleanly any answer that you wish to change
Make no stray marks of any kind on the form
For food that you never or rarely eat, please mark the first column labeled “None or
Less than once a month. Please do not leave any food items blank.
6. Please note the correct way to mark the answers.
Correct Mark

Incorrect Mark

Please answer the following. Check the appropriate gender, and fill in your height, weight, and age
Male_____

Female_____

Height_____

Weight_____

THANK YOU!!!!

Age_____
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DIETARY SUPPLEMENTS
PLEASE INDICATE WHICH, IF ANY, OF THE FOLLOWING SUPPLEMENTS YOU ARE
CURRENTLY TAKING. PLEASE ANSWER “YES” OR “NO” FOR ANY SUPPLEMENT
LISTED.
1.

Do you regularly take multivitamins
NO> PLEASE GO TO QUESTION 2
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
2-4 years

5-9 years
10 or more years

(B) What specific brand do you use?__________________________
Excluding multivitamins, do you take any of the following supplements listed below?
2.

Do you regularly take Vitamin A?
NO> PLEASE GO TO QUESTION 3
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
less than 8,000 IU
22,001 IU or more
8,001 to 13,000 IU
Don’t know
13,001 to 22,000 IU

3.

Do you regularly take Vitamin C?
NO> PLEASE GO TO QUESTION 4
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
less than 400 mg
1301 mg or more
401 to 700 mg
Don’t know
701 to 1300 mg

4.

Do you regularly take Vitamin C?
NO> PLEASE GO TO QUESTION 5
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
less than 100IU
504 IU or more
101 to 300 IU Don’t know
301 to 500 IU
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5.

Do you regularly take Calcium?
NO> PLEASE GO TO QUESTION 6
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
less than 400 mg
1301 mg or more
401 to 900 mg
Don’t know
901 to 1300 mg

6.

Do you regularly take Vitamin D?
NO> PLEASE GO TO QUESTION 7
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
less than 200 IU
1,000 IU or more
201 to 400 IU Don’t know
401 to 1,000 IU

7.

Do you regularly take Vitamin B6?
NO> PLEASE GO TO QUESTION 8
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
less than 10 mg
80 mg or more
10 to 39 mg
Don’t know
40 to 79 mg

Do you regularly take Selenium?
NO> PLEASE GO TO QUESTION 9
YES> CONTINUE:
(A) How many years have you taken multivitamins?

8.

0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
less than 80 mcg
251 mcg or more
81 to 130 mcg
Don’t know
131 to 250 mcg
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9.

Do you regularly take Iron?
NO> PLEASE GO TO QUESTION 10
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
50 mg or less
401 mg or more
51 to 200 mg
Don’t know
201 to 400 mg

10.

Do you regularly take Zinc?
NO> PLEASE GO TO NEXT SECTION
YES> CONTINUE:
(A) How many years have you taken multivitamins?
0-1 years
5-9 years
2-4 years
10 or more years
(B) What dose do you take per day?
less than 25 mg
101 mg or more
26 to 75 mg
Don’t know
76 to 100 mg

11. DO YOU TAKE ANY OF THE FOLLOWING OTHER SUPPLEMENTS:
Cod liver oil ........... Yes ........... No

Folic acid............... Yes ........... No

Other fish oil .......... Yes ........... No

Iodine .................... Yes ........... No

Niacin..................... Yes ........... No

Brewer’s Yeast ...... Yes ........... No

Beta-caroten ........... Yes ........... No

Magnesium............ Yes ........... No

Thiamine (vitamin B1)..... Yes .... No

Any others? ........... Yes ........... No

B-complex vitamins ......... Yes .... No

If yes, please specify_____________________
______________________________________
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FOODS YOU EAT
For each food listed, please mark a
circle for how often during the past
year, on average, you have eaten the
serving size specified. Be sure to mark
a circle for every food listed. If you
never eat the food listed mark the
circle in the first column.
DAIRY FOODS
Skim or low fat milk (8 oz. glass)
Whole milk (8 oz. glass)
Chocolate milk or cocoa (8 oz. glass)
Cream or half-and-half, e.g. coffee,
whipped (Tbs)
Sour cream (Tbs)
Non-dairy coffee whitener (tsp)
Sherbet, ice milk, or frozen yogurt (1/2
cup)
Ice cream (1/2 cup)
Yogurt (1 cup)
Cottage or ricotta cheese (1/2 cup)
Cream cheese (1 oz.)
Other cheese, e.g. American, cheddar,
etc., plain or as part of a dish (1 slice or 1
oz. serving)
Margarine (1 tsp, added to food or bread;
exclude use in cooking
Butter (1 tsp), added to food or bread;
exclude use in cooking.
FRUITS
Raisins (1 oz. or small pack ) or grapes
(1/2 c)

AVERAGE USE FOR PAST 12 MONTHS
NONE
OR
LESS
THAN
1
PER
MO.

1-3
PER
MO.

1 PER
WK.

2-4
PER
WK.

5-6
PER
WK.

1
PER
DAY

2-3
PER
DAY

4-5
PER
DAY

6
PER
DAY
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Prunes (7 prunes or ½ cup)
Bananas (1)
Cantaloupe (1/4 melon)
Avocado (1/2 fruit or ½ cup)
Fresh apples or pears (1)
Apple juice or cider (small glass)
Oranges (1)
Orange Juice (small glass)
Grapefruit (1/2)
Grapefruit juice (small glass)
Other fruit juices (small glass)
Strawberries, fresh, frozen or canned (1/2
cup)
Blueberries, fresh, frozen or canned (1/2
cup)
Peaches, apricots or plums (1 fresh, or ½
cup canned)
VEGETABLES
Tomatoes (1)
Tomato juice, V8 (small glass)
Tomato sauce (1/2 cup) e.g. spaghetti
sauce
Salsa or red chili sauce (1 Tbs)
Tofu or soybeans (3-4 oz.)
String (green) beans (1/2 cup)
Broccoli (1/2 cup)
Cabbage or cole slaw (1/2 cup)
Cauliflower (1/2 cup)
Brussels sprouts (1/2 cup)
Carrots, raw (1/2 carrot or 4 sticks)
Carrots, cooked (1/2 cup) or carrot juice
(2-3 oz.)
Red Beets—not greens (1/2 cup)
Corn (1 ear or ½ cup frozen or canned)
Peas or lima beans (1/2 cup fresh, frozen,
or canned)
Mixed vegetables (1/2 cup)
Beans or lentils, baked or dried (1/2 cup)
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Dark orange (winter) squash (1/2 cup)
(acorn, butternut squash)
Eggplant, zucchini or other summer
squash (1/2 cup)
Yams or sweet potatoes (1/2 cup)
Spinach, cooked (1/2 cup)
Spinach, raw as in a salad (1 cup serving)
Kale, mustard or chard greens (1/2 cup)
Iceberg or head lettuce (1 cup serving)
Romaine or leaf lettuce (1 cup serving)
Celery (2-4 4” sticks)
Sweet green or red peppers (3 slices or ¼
pepper)
Onions as a garnish, or in salad (1 slice)
Onions as a vegetable, rings or in soup (1
onion)
EGGS, MEATS, ETC.
Eggs (1)
Chicken with skin (4-6 oz.)
Chicken without the skin (4-6 oz.),
includes grilled chicken sandwich
Turkey, including ground turkey (4-6 oz.
or 2 turkey dogs)
Hot dogs 91)
Bacon (2 slices)
Processed meats, e.g. sausage, salami,
bologna, etc. (1 piece or slice)
Hamburger (1 patty)
Taco or tostado (1)
Burrito (1)
Enchilada (2)
Beef, pork or lamb as a sandwich or
mixed dish, e.g. stew, casserole, lasagna,
chili etc.
Pork as a main dish, e.g. ham or chops (46 oz.)
Beef or lamb as a main dish, e.g. steak,
roast (4-6 oz)
Liver: beef, calf, or pork (4 oz)
Liver: chicken or turkey (2 oz)
Canned tuna fish (3-4 oz)
Dark meat fish, e.g. mackerel, salmon,
sardines, bluefish, swordfish (3-5 oz.)
Fried fish, e.g. fish sticks, fish and chips
style fish (3-5 oz.)
Other fish (3-5 oz.)
Shrimp, lobster, scallops as a main dish

85

BREADS, CEREALS, STARCHES
Cold breakfast cereal (1 cup)
Cooked oatmeal/cooked oat bran ( 1 cup)
Other cooked breakfast cereal (1 cup)
Instant breakfast beverage, e.g. Carnation
White bread (slice), including pita bread
Dark bread (slice), including pita bread
English muffins, bagels, or dinner rolls (1
each)
Muffins or biscuits (1 each)
White rice (1 cup)
Pasta, e.g. spaghetti, noodles, etc (1 cup)
Tortillas (1-10 inch shell)
Other grains, e.g. bulgur, kasha,
couscous, etc ( 1 cup)
Pancakes or waffles (2 each)
French fried potatoes (4 oz. or size of
small fries order)
Potatoes, baked, boiled (1each), or
mashed (1 cup)
Potato chips or corn chips (small bag or 1
oz.)
Crackers, e.g. Triscuits, Wheat Things (5
each)
Pizza (2 slices)
BEVERAGES
Plain water, bottled or tap (1 cup or 8 oz.
glass)
Hawaiian Punch, lemonade, or other noncarbonated fruit drinks ( 1 glass, bottle,
can)
Low-calorie cola, e.g. Diet Coke with
caffeine (can)
Low-calorie caffeine-free cola (can)
Other low-calorie carbonated beverage,
e.g. Fresca, Diet 7-UP (can)
7-Up, diet ginger ale (can)
Coke, Pepsi, or other cola with sugar
(can)
Caffeine Free Coke, Pepsi, or other cola
with sugar (can)
Other carbonated beverages with sugar,
e.g. Sprite, Root beer (can)
Regular Beer (1 glass, bottle, or can)
Light Beer (1 glass, bottle, or can)
Red wine (4 oz. glass)
White Wine (4 oz. glass)

86

Liquor, e.g. whiskey, gin, etc (1 drink or
shot)
Dark tea with caffeine (1 cup), not herbal
tea
Green tea or herbal tea (1 cup)
Coffee with caffeine (1 cup)
Decaffeinated coffee (1 cup)
SWEETS, BAKED BGOODS, MISC

Chocolate (bar or packet) e.g. Hershey’s
M & M’s
Candy bars, e.g. Snicker, milky way,
Reeses
Candy other than chocolate (1 oz)
Cookies, home baked (1)
Cookies, ready make (1)
Brownies (1)
Doughnuts (1)
Cake, home baked (1 slice)
Cake, ready make (1 slice)
Pie, homemade ( 1 slice)
Pie, ready made ( 1 slice)
Sweet roll, coffee cake or other pastry,
home baked (1 each)
Sweet roll, coffee cake or other pastry,
ready made (1 each)
Jams, jellies, preserves, syrup, or honey
(1 Tbs)
Peanut butter ( 1 Tbs)
Popcorn (1 cup)
Peanuts (small packet or 1 oz.)
Other nuts (small packet or 1 oz.)
Oat bran, added to food (1 Tbs)
Other bran, added to food (1Tbs)
Wheat germ (1 Tbs)
Chowder or cream soup (1 cup)
Olive oil salad dressing (1 Tbs)
Other oil and vinegar dressing, e. g.
Italian (1 Tbs)
Mayonnaise or other creamy salad
dressing ( 1 Tbs)
Salt added at table (1 shake)
Garlic (1 clove or 4 shakes)

1.

FOOD PREPARATION
Do you eat cold breakfast cereal?
NO> PLEASE GO TO NEXT QUESTION
YES> What kind do you usually eat?______________________________________
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2.

How many teaspoons of sugar do you add to your beverages or food each day?
0-1
2-4
5-9 10 or more
When you have beef or lamb as a main dish, how is the meat cooked?
Rare
medium
well
Medium rare medium well
do not eat meat
How much of the visible fat on your beef, pork, or lamb do you remove before eating?

3.

4.

remove all visible fat
remove none
remove most visible fat
do not eat meat
remove small part of visible fat

5.

How often do you eat food that is fried at home? (exclude Pam-type spray)
less than once per week
1-3 times per week

6.

4-6 times per week
daily

How often do you eat fried food away from home? (e.g. french fries, fried chicken, fried
fish).
less than once per week
1-3 times per week

7.

4-6 times per week
daily

What type and brand of cooking oil or fat do you usually use at home (e.g. corn oil,
Mazola brand; lard)
Type:_________________________________________________
Brand:________________________________________________
How does the amount of food you eat now compare to the amount you ate five years ago?

8.

I eat almost the same
I eat less now
I eat more now

9.

What was the main source of your drinking water over the past year?
city system
rural or county system
private well
bottled water
other (please specify______________________________________________)

FOR OFFICE USE ONLY
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YOUR ACTIVITES
1.

About how many hours per day do you spend in light activity, such as walking, shopping,
child care, cooking, carrying light objects, cleaning, and repairing?
Hours per day_________

2.

About how often do you take part in moderate physical activities including bowling, golf,
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light swimming, gardening, walks over 15 minutes, fishing, light bicycling, or other light
sports.
Usually every day
2-6 times a week
About once a week
A few times a month
A few times a year
Rarely or never
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3.

About how often do you take part in vigorous physical activity including jobbing, tennis,
racquetball or squash, lap swimming, aerobics, vigorous bicycling, skiing, hiking, hunting
or other vigorous sports…
Usually every day
2-6 times a week
About once a week
A few times a month
A few times a year
Rarely or never

4.

How often do you talk on the telephone with family, friends, or neighbors?
Usually every day
2-6 times a week
About once a week
A few times a month
A few times a year
Rarely or never

5.

How often do you get together with family, friends, or neighbors? This includes meeting
in your own home, meeting in other’s homes, or going out together.
Usually every day
2-6 times a week
About once a week
A few times a month
A few times a year
Rarely or never

6.

How often do you attend meetings of social clubs, groups, or organizations such as bridge
clubs, book clubs, hospital volunteer, gardening clubs, Rotary club, Kiwanis, VFW, etc.
Usually every day
2-6 times a week
About once a week
A few times a month
A few times a year
Rarely or never

Thank you for completing this questionnaire. Please make sure that no questions or pages have
been skipped. Please place it in the postage-paid envelope that has been provided and seal it.
Please return it to us in the mail.
Thank you for your time and cooperation. You have made an important contribution to our
study of nutrition and health.
Utah State University

